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Abstract 
Intrinsically disordered proteins (IDPs) represent 30% of the human genome. They are 
frequently involved in a variety of diseases including neurodegenerative disorders, cancer 
and cardiovascular diseases. Interfering with the function of disease-associated IDPs 
offers a highly attractive objective for drug development. Unfortunately, the highly 
dynamic nature of IDPs, the presence of continuous local and global conformational 
rearrangements, the transient secondary and long-range tertiary structure pose serious 
limits to experimental approaches aimed at designing rationally new drugs. 
Computational methods may be of great help to characterize IDPs and their binding to 
drugs, yet they also faces critical challenges in sampling the wide IDPs’ conformational 
space, with force field and analysis tools tailored for structured proteins.   
My thesis addresses IDPs computational issues by adopting apt computational protocols, 
combined with new analysis tools developed here. I focus on human α-synuclein (AS), a 
presynaptic protein of poorly defined function, whose aggregations constitute the main 
component of Parkinson disease-associated Lewy bodies.  
The first aim of this thesis is to characterize the structural determinants of the binding 
between AS and an anti-aggregation ligand, dopamine (DOP), which has been shown to 
prevent aggregation.  We developed a new conformational analysis tool based on 
directional statistics. The tool not only is able to detect and quantitatively analyze protein 
residues’ flexibility and backbone conformational transitions, it is also able to 
quantitative detect the effects of the ligand on the dynamical spectra of the protein, 
avoiding problems associated with usual computational analysis tools based on Cartesian 
coordinates, which are biased by the problematic alignment of extremely flexible 
structures, besides being affected by the movements of neighboring residues. This tool 
provided a rationale for experimentally observed changes in chemical shifts on passing 
from free AS to AS DOP adducts, distinguishing variations arising from conformational 
rearrangements of residues with respect to the ones due to direct contacts with the drug. 
The second aim of the thesis is to adapt an enhanced sampling method to investigate the 
changes  of conformational ensemble upon a physiologically relevant chemical 
modification, the N-term acetylation, recently revealed in human cells.  
The degree of sampling of our simulations and the quality of our models, in the first and 
second project, has been carefully validated against experimental data. Structural 
experimental quantities have been successfully reproduced.  
The methods proposed in my thesis provide a solid computational framework, which 
could be of great help for the characterization of the structural determinants of IDPs of 
pharmacological relevance also in the presence of drugs. Computational and semi-
quantitative characterizations methods, like the ones adopted here, may provide crucial 
insights for future therapeutic strategies in drug design.  
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1Almost all of biophysical studies on AS have been taken on bacterially expressed protein that lacks the N-terminal 
acetylation.[5] 	  
1Almost all of biophysical studies on AS have been taken on bacterially expressed protein that lacks the N-terminal 
acetylation.[5] 	  
CHAPTER 1 
 
 
 
 
 
1. INTRODUCTION 
 
Intrinsically disordered proteins (IDPs), i.e. proteins which do not have defined secondary 
structures, constitute the ~30% of the human genome. They are involved in a variety of 
diseases including cancer and neurodegenerative disorders {Uversky, 2008 
#338;Iakoucheva, 2002 #134. Specifically, the 79% of cancer associated proteins, the 
57% of the cardiovascular disease associated proteins and the 55% of neurodegenerative 
disease associated proteins are predicted to contain 30 or more consecutive disordered 
residues [1,2]. Hence, interfering with the function of disease-associated IDPs offers a 
highly attractive objective for drug development. Unfortunately, rational drug-design 
approaches have been hampered so far by a variety of both experimental and 
computational challenges, absent in traditional drug design protocols: IDPs exist as 
dynamic, highly flexible structural ensembles that undergo conformational conversions 
on a wide range of timescales, spanning from picoseconds to milliseconds [3]. Moreover 
IDPs present long-range conformational rearrangements, transient secondary and long-
range tertiary structure and low overall hydrophobicity combined to high net charge [1,4-
8], which make them difficult for experimental studies.  
Classical molecular dynamics (MD) simulations may be of great help to characterize 
IDPs and their binding to drugs. Yet it also faces few more major challenges in addition 
to experiments.  
A first challenge is related to IDPs' large conformational space [9]. Despite MD may 
reach the sub-microsecond time scale, this could be an insufficient time to achieve 
convergence in IDPs conformational space if one starts from modeled structural 
ensembles. Implicit solvent [10,11] models, which reduces the system size and the 
computational costs, have been successfully applied to modeling small IDPs [10,12,13], 
sometimes combined with Monte Carlo Approaches [14]. However implicit solvent 
algorithms over-stabilizes non-specific collapsed states [15] and they are limited by the 
lack of solvent-induced short-range effects. Well-converged structural ensembles of IDPs 
can be also obtained on small disordered peptides [16-19] by advanced enhance sampling 
techniques as the replica exchange methods [20,21]. However, the efficacy of replica 
exchange for IDPs can be challenging since the nature of IDPs sub-states and the energy 
barriers of their inter-conversion are not known and the maximum temperature should be 
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carefully estimated slightly above where the folding rate maximizes [22,23].  
A second challenge regards the accuracy of the potential energy used. Standard 
biomolecular force-fields may be not very well tested for IDPs [24-28] as they have been 
constructed for structured proteins [29,30]. Therefore their domain of applicability to 
IDPs remains to be established. 
A final challenge regards the analysis of the simulated data. The majority of 
computational-bases analysis tools for MD relays on Cartesian coordinates which are 
biased by the problematic alignment of extremely flexible structures, besides being 
affected by the movements of neighboring residues [31]. 
My thesis attempts to face these challenges by adopting apt computational protocols, 
which use in part also novel tools, developed here. We perform simulations on human α-
synuclein (AS), which is a pharmacologically relevant IDP1 for which a large number of 
biophysical data are accessible [30]. Specifically we first focus on how an anti-
aggregation drug-candidate, dopamine (DOP)2, impacts on AS structure (first project); 
next we study how a crucial naturally occurring chemical modification (acetylation) 
affect AS conformational ensemble (second project). 
We face our first challenge on conformational sampling by performing MD simulations 
based on realistic configurations of AS obtained by NMR spectroscopy combined with 
paramagnetic Relaxation Enhancement (PRE), instead of using randomly generated 
conformations. Specifically, our initial models for AS in the free non-acetylated form 
were obtained from a cluster analysis on ~4,000 NMR structures [30] and cover almost 
three quarters of AS conformations. 
For the second issue concerning force-fields accuracy, we performed classical molecular 
dynamics (MD) based on amber parm99SB force field [29] with ildn modification [37] 
[38], which has been already successfully used to investigate qualitatively the effect of 
disease-causing mutations in AS [39].  
For the third issue, we develop a new analysis tool based on dihedral angles distributions, 
sampled by a protein during MD simulations, treated with directional statistics formalism 
[31]. The proposed tool is able to quantitatively analyze protein residues’ flexibility and 
backbone conformational transitions. 
In the first project, for detecting the structural effects of DOP binding on AS 
conformational ensemble, we first perform MD simulations of AS, in the presence and in 
the absence of the drug. The degree of sampling of our AS simulations and the quality of 
our models, with and without the drug, have been carefully validated against 
experimental data. These include mono- and multi-dimensional NMR spectra (some of 
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
1 AS is implicated in Parkinsons’ disease (PD) [32], a degenerative disorder affecting from seven to 10 million people 
worldwide [33] 
2 dopamine (DOP), whose inhibitory effect on the fibril formation process of the protein in vitro has been established [34] 
[35] [36].	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which measured by our collaborator P. Selenko, In cell NMR Laboratory, Leibniz 
Institute of Molecular Pharmacology (FMP Berlin), Department of NMR-supported 
Structural Biology, Berlin, Germany) and Residual Dipolar Couplings (RDCs); our 
calculated NMR chemical shifts and RDCs turned out to agree well with the experimental 
ones [40-44]. Moreover we were also able to reproduce structural experimental quantities 
as the secondary structure content {Outeiro, 2009 #235;Rekas, 2010 #266;Herrera, 2008 
#115} and gyration radius [30,39] for AS.	   
Next we applied a newly designed tool [31] which quantitatively characterized the change 
of conformational transitions and of fluctuations of AS induced by the drug on the 
dynamical spectra of the protein, an unprecedented obtained result. This tool uses as input 
the AS and AS/DOP trajectories and it avoids problems associated with Cartesian 
coordinates described above. We used our tool to provide a rationale for experimentally 
observed changes in chemical shifts of AS in the presence of DOP.  
In the second project, for investigating the effect of the acetylation at N-terminus of AS 
[45,46], on the AS structural ensemble, we enhanced the sampling by using the replica 
exchange with solute tempering (REST) method [47]. This methodology is particularly 
suitable for systems as large as those considered here since the system (e.g. protein 
solvated in water) is split into two parts: the solute molecule (AS protein in our case) and 
the solvent molecules (water in our case); only the solute is simulated at different 
effective temperatures by applying an appropriate potential energy function to each 
replica at different temperatures, while the solvent effective temperature is the same in all 
the replicas. The optimal setup for all the six AS systems has been obtained. By 
performing a preliminary analysis on our trajectories, the structural quantities (as radii of 
gyration and secondary structure percentage) calculated at the present stage of the 
simulations for all the AS systems are in good agreement with the experimental available 
data [45,46,48]. 
The methods proposed in my thesis provide a solid computational framework, which 
could be used to characterize other IDPs of pharmacological relevance and their binding 
to drugs. This knowledge may help in design new drugs interfering with some of their 
pathogenic behaviors. 
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CHAPTER 2 
 
 
 
 
 
2. INTRINSICALLY DISORDERED PROTEINS  
 
2.1 INTRODUCTION 
 
IDPs are commonly defined as proteins that does not adopt a well-defined native three-
dimensional structure [49]. They exist in an ensemble of states in vitro and in vivo [50] 
and they lack stable tertiary and/or secondary structures in vitro under near-physiological 
conditions [50,51].  
IDPs are common in human and other genomes [52-54]. They represent almost one third 
of the human genome [1,4,5,55,56] and the genome fraction encoding IDPs increases 
with the complexity of organisms[54,57]. About 30% of the human proteome [58,59] 
consists of IDPs or it contains disordered regions of significant length (>50 consecutive 
amino acids).  
 
IDPs are among the major cellular regulators, recognizers, and signal transducers [60].3 
More specifically, IDPs are involved in many important cellular processes such as the 
regulation of gene expression at the levels of transcription and translation, regulation of 
the cell cycle, cellular signal transduction, protein phosphorylation, the storage of small 
molecules, and the regulation of the self-assembly of large multi-protein complexes such 
as the bacterial flagellum and the ribosome [72]. They also function in protein nucleic 
acid recognition as DNA binding proteins and RNA binding proteins [55,63]. IDPs are 
also found in chaperones for other proteins and for RNA [73].  Hence, IDP are associated 
with a variety of biological functions [55]. IDP's conformational diversity, far from being 
an unusual quirk of a few peculiar proteins, is intimately connected with protein function 
[74]. 
 
IDPs are abundant in proteins implicated to human disease, including the majority of 
cancer [57,75-79], cardiovascular [80],  amyloidosis and neurodegenerative [51] diseases.  
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
3 IDPs' function often involves protein binding [55] [61]. This occurs via molecular recognition mechanisms other than 
those of structured proteins [62,63]. Indeed, IDPs may undergo a disorder-to-order transition upon protein binding [64] 
[65] [66] [67,68] [50,69-71]  (folding-upon-binding mechanism). 
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Interfering with the function of disease-associated IDPs represent therefore a highly 
attractive novel class of drug targets that aims to modulate protein-protein interactions 
[80-83]. Novel strategies for drug discovery based on IDPs have recently been developed 
and are in the process of being implemented [84]. Investigating the mechanism by which 
IDPs acquire structure upon binding to their specific partners is technically challenging as 
the structural flexibility of IDPs limits the number of suitable techniques.  
 
2.2 CHARACTERISTIC FEATURES OF IDPS  
 
IDPs' amino acid composition is enriched in A, R, G, Q, S, P, E and K while depleted in 
W, C, F, I, Y, V, L and N [85,86]. Lysine, glutamine, serine, glutamic acid and proline 
are disorder-promoting amino acids of low hydrophobicity and high net charge [87]. This 
combination of the low hydrophobicity and relatively high net charge contribute to their 
lack of compact structure under physiological conditions [56]. The secondary structure is 
typically transient and confined to short individual helical or extended segments	   [88]. 
Because these segments often comprise a small fraction of the total protein sequence, 
they are typically difficult to detect them experimentally [89-91].  
IDPs' conformational energy landscape is a rugged one, hosting an ensemble of 
conformers at similar free energy	   [92], with small free energy barriers among them.  
Hence the conformers are continuously  interconverting [93]. Changes of micro-
environmental conditions, like the presence of a ligand may lead the landscape to deepen 
or flatten, driving the IDPs towards different structural states and/or differently populated 
sets of structures [2,92]. IDPs show different mobility in different regions [89]. 
 
2.3 EXPERIMENTAL CHARACTERIZATIONS OF IDPS 
 
Progresses have been made in prediction, identification and general characterization of 
IDPs by a variety of biophysical methods [60,89,94,95]. 
Circular dichroism (CD) and infrared spectroscopic techniques can probe the fractions of 
IDP residues involved in transient α -helical or β -strand secondary structures [96]. 
However, these methods provide only semi-quantitative estimates of secondary structure 
distinguishing ordered and molten globular forms from random coil. They do not provide 
clear information for IDPs that contain both ordered and disordered regions, lacking 
residue-specific information [97,98]. 
Fluorescence spectroscopy (FS) can provide information about rates of protein 
conformational change by measuring changes in the diffusion coefficient over a broad 
range of time scales [99]. As the protein takes on more compact or more extended 
conformations, the hydrodynamic radius and consequently the diffusion coefficient 
change correspondingly; if these changes are large enough, they can be observed in FS 
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measurements [99]. FS can probe similar inter-residue distances, as well as the 
reconfiguration within the solution-state ensemble [100].  
Small-angle X-ray scattering (SAXS) [13] and diffusion-based measurements [101,102] 
can provide measures of global dimension and relevant structural information such as the 
size, shape, compactness and oligomeric state of the protein. SAXS patterns indeed arise 
from the X-ray photons elastically scattered from particles present in the sample and it 
has the capacity to report on the 3D space sampled by disordered states offering an 
overall picture of the space occupied by coexisting conformations [13]. Moreover, the 
measured intensity in SAXS experiments is the population-weighted average of the 
individual scattering curves derived from the different conformations present in solution 
[13]. The analysis of SAXS curves is therefore a powerful tool for the quantitative 
analysis of flexible systems, as IDPs, and it is highly complementary to the high 
resolution experimental techniques as X-ray crystallography and NMR to identify 
unstructured regions in proteins [103,104].  
X-ray crystallography recognizes disorder from the missing electron density in protein 
structures [105]. The absence of interpretable electron density for some sections of the 
structure is usually associated with the increased mobility of atoms in these regions, 
which leads to the non-coherent X-ray scattering, making atoms invisible	   [106]. 
However, the missing region may not necessary correspond to a disorder region but could 
also be a “wobble domain” i.e., structured domains attached to the rest of the protein by a 
highly flexible (disordered) linker	   [59]. Therefore, the major uncertainty regarding 
information from X-ray diffraction is that, without additional experiments, it is unclear 
whether a region of missing electron density is a wobbly domain, intrinsically disordered, 
or it is the result of technical difficulties [50]. 
Nuclear magnetic resonance (NMR) and electron paramagnetic resonance (EPR) are 
particularly rich in both short-range and long-range structural information that can be 
exploited to accurately define the behavior of IDPs [107]. Among a wide range of 
biophysical techniques available for characterizing disordered protein states [89], 
biomolecular solution state NMR spectroscopic techniques has been probably the most 
comprehensive [108] and the main tool to study IDP structure by probing conformational 
preferences at residue level [109]. 
NMR methods allows the exploration of a wide range of dynamic phenomena of IDP 
thanks to the different sensitivity of the large variety of NMR observables that can be 
measured using different techniques [91]: chemical shift, coupling constant, nuclear 
Overhauser effect, residual dipolar coupling, paramagnetic resonance enhancement, and 
spin relaxation. They have been applied to derive important insights on many disordered 
protein states (see recent reviews [13,55,108,110]). In detail, a brief description on how 
NMR observables are used for IDP characterization is reported below:  
Chemical shifts (CS) are the simplest measurable parameter, describing the dependence 
of the nuclear magnetic energy levels on the electronic environment of a nucleus. They 
report essentially the local physico-chemical environment of the nucleus of interest [111] 
[112]. IDPs, owing to their inherent plasticity, display chemical shifts which are close to 
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the random-coil values, and departures from them, particularly for backbone carbon 
atoms, indicate the presence of secondary-structural elements [113]. In the context of 
IDPs, CS are very useful for monitoring disorder-to-order transitions upon binding to 
partners, or structural perturbations upon post-translational modifications [114,115].  
Nuclear Overhauser Effect (NOE) [116], i.e.  the transfer of nuclear spin 
polarization from one nuclear spin population to another via cross-relaxation, detects 
detailed information about local conformational sampling [117]. Sequential and medium-
range NOEs can usually be observed in IDPs, but long-range NOEs are rarely present. 
The fast dynamics of IDPs indeed diminishes NOE signals, and if NOE signals are 
present, the high degeneracy of side chain chemical shifts makes peak assignment 
ambiguous [89]. Short-range NOE can be however used to corroborate secondary 
structure propensities detected through chemical shifts [118,119], such as in the case of 
tau protein, where short-range NOEs have been used to confirm structure propensities 
inferred from chemical shifts [120].  
Residual dipolar coupling (RDC) is measured between pair of nuclei in partially aligned 
protein leading to an incomplete averaging of spatially anisotropic dipolar couplings 
[121]. RDCs provide both local and long-range orientational information describing the 
net alignment of the protein relative to the external applied magnetic field [91]. The 
remarkable sensitivity for structured elements makes RDCs an excellent tool for probing 
structure propensities and conformational behavior of IDPs [122]. Moreover, the analysis 
of RDCs of different bond vectors along the protein backbone is sensitive to transient 
long-range order in IDPs [8,122]. 
Chemical shifts, coupling constants and NOEs can be used to determine secondary 
structure propensities semi-quantitatively at the residue level [123-126]. 
Paramagnetic Relaxation Enhancement (PRE) [127] provides long-range information 
extracted from dipolar relaxation between an unpaired electron (normally present due to 
an artificially introduced nitroxide group) and the observed spin [128,129]. The spin label 
has to be placed at carefully chosen positions not to influence or disturb structure 
formation, and it has to be considered that the mutations necessary for the introduction 
and removal of cysteine residues might affect the structure and dynamics of an IDP. [8]. 
In the case of α-synuclein, for example, PREs were successfully used to map long-range 
interactions [30], and later as distance restraints in molecular dynamics simulations to 
determine its free energy landscape [130]. 
PRE and RDC are powerful tools for uncovering the existence of transient tertiary 
organizations [127,131].  
In this thesis the initial structures of AS used are based on ~4000 AS experimental 
structural ensembles in aqueous solution, obtained by NMR combined with PRE 
measurements [30,39]. Specifically, we used the six AS configurations obtained through 
a clustering analysis, representing the 73% of the overall experimental population [132].  
Despite NMR efficacy, however, compared with ordered proteins, relatively few IDPs 
have been structurally characterized by NMR, indicating the existence of significant 
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experimental difficulties [24].  
First, proteins with disordered regions often aggregate at concentrations needed for NMR 
[50]. Second, IDPs are heterogeneous and exhibit on the millisecond timescale (the NMR 
timescale) rapid backbone motions throughout the polypeptide chain, in contrast to well-
structured systems where such motions are typically restricted to hinge or loop regions 
[91]. This leads to extreme broadening of the side-chain NMR peaks [50]. NMR 
backbone data on IDPs are also difficult since the absence of a stable 3D structure causes 
a lack of chemical shift dispersion (rather than extreme line broadening) originating 
severe resonance overlap, which in turn causes very poor peak separation making 
resonance assignment difficult, even for relatively small disordered protein fragments 
[133]. In addition, the more solvent-exposed nature of IDP polypeptide chain also favours 
very efficient exchange processes with the solvent, which may cause broadening of the 
signals of exchangeable protons beyond detection [109].  
Some of these obstacles are solved in multidimensional heteronuclear NMR methods 
[134], where 1H is usually correlated with 13C or 15N, whose resonances are more 
dispersed than those of protons [135,136]. The spread of the peaks in additional 
dimensions indeed mitigates the overlap problem [137]. Moreover, the chemical shifts of 
15N and 13C nuclei of proteins are very sensitive to the side-chain identities giving rise to 
much better resolved spectra than those based on 1H [138]. Finally, they can reduce the 
impact of line broadening due to chemical exchange [139]. Within the multidimensional 
NMR techniques, the Heteronuclear Multiple Quantum Correlation (HMQC) experiments 
(as well as Heteronuclear Single Quantum Coherence (HSQC)) give signals based upon 
coupling between nuclei, which can occur through space (i.e. the two nuclei are 
physically close to each other - within about 5 Å) or through bonds (i.e. the two nuclei are 
separated by 1 to 4 chemical bonds)4 [108,134]. The two methods give similar qualitative 
results for small to medium sized molecules, but HSQC is considered to be superior for 
larger molecules [140].  These methods are well suited for IDP since they provide 
structural information in short record-time and helps to detect changes in chemical shifts 
or peak intensities arising from molecular interactions, conformational transitions and 
chemical exchanges, resolving ambiguities [141]. Indeed, they have been successfully 
used to characterize ligand-binding on IDPs [142,143]. 
The spectra presented in this thesis make use of HMQC recorded with Selective 
Optimized-Flip-Angle Short-Transient (SOFAST) [142,144], since it can provide 
increased sensitivity and a higher resolution spectra within few seconds of data 
acquisition [142,144]. This method is based on the optimization of longitudinal relaxation 
that allows a substantially higher repetition rate and, therefore, a shorter total 
accumulation time [142,144]. This is well suited to the study of IDPs due to their 
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
4 The first can be measured by the NOE by which nearby atoms (within about 5 Å) undergo cross relaxation by a 
mechanism related to spin-lattice relaxation. In the case of IDPs, long-range NOEs are generally missing from the NOESY 
spectra [108] In IDPs, these contacts are indeed present only in a small fraction of the conformational ensemble, and, the 
very rapid dynamics of internuclear proton–proton vectors diminishes the NOE intensities. Even if present, however, the 
unambiguous assignment of NOE peaks in IDPs is severely hindered by the high degeneracy of side-chain proton chemical 
shifts [134] 
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transient secondary structure and their highly dynamic nature [142,144]. This technique is 
able to detect fast conformational changes and binding events also with high resolution 
and within a short time [142,144].  Unfortunately, however, discriminating the 
contributions of spectral changes on passing from the protein alone to that in complex 
with a ligand is challenging. Indeed, these contributions are due to direct contacts formed 
between the protein and the ligand and/or those due to conformational transitions 
associated with long-range effects [8] of the ligand. This prevents a quantitative 
assessment of the structural determinants of ligands/IDPs complexes [145]. In other 
words, it is not always possible to identify with certainty the amino acids in direct contact 
with the ligands. 
In this thesis I contribute with computational methods to solve this issue 
 
2.4  CHARACTERIZATION OF IDPS VIA COMPUTATIONAL METHODS: TECHNIQUES 
AND CHALLENGES  
 
Despite the detailed information that can be obtained from experiments, describing the 
ensemble of conformations of IDP at atomistic level remains a considerable challenge. 
Computational methods using physics-based empirical molecular mechanics force fields 
increasingly release critical contributions in providing general insights into the behavior 
of IDPs [146,147], despite the dynamic and heterogeneous nature of IDPs presents 
substantial new challenges, and pushing the limit on both force field accuracy and 
conformational sampling capability. 
 
2.4.1 Force field accuracy.  
Molecular dynamic simulations are sensitive to the choice of the protein force field 
[37,146,148]. An important caveat is that these force fields are typically parameterized to 
reproduce the behaviour of folded proteins rather than IDPs, and thus they may fail to 
capture important aspects of IDP ensembles [149-151]. In this thesis we used the Amber 
parm99SB force field [29] with ildn modification [37,38], which has been already 
successfully used to investigate qualitatively the effect of disease-causing mutations in 
AS [39].  
 
2.4.2 Conformational sampling. 
In the following paragraph I will describe the different techniques used for IDPs and how 
they deal with IDPs’ issues. 
Molecular dynamics (MD) and Monte Carlo (MC) computer simulations have the 
potential to complement experiments by elucidating the chemical details underlying the 
conformational dynamics of biological macromolecules [152]. Unfortunately, it is 
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extremely difficult to adequately sample the conformational space accessible to 
biomolecules especially for IDPs. In details: 
- Classical MD employs a physical representation of a protein chain and evolves the 
system over time according to the Newtonian equations of motion. Classical MD 
simulations in explicit solvent at room temperature are generally insufficient to fully 
explore the structural ensembles of IDPs, because of their large conformational space[9] 
and because of the problem known as “kinetic trapping”, namely when the system tends 
to be confined to local energy minima [153]. Such minima are separated by free-energy 
barriers, whose heights are often much larger than the thermal energy of the system [153]. 
Therefore, classical MD is not always suitable to adequately sample the dynamical 
behavior of IDPs.  In this thesis, we have successfully used MD for an IDP, the alpha-
synuclein, since our starting configurations are taken from an experimentally determined 
ensemble of configurations already representing 70% of the conformational space of the 
protein (see Chapter 5). 
- MC approaches rely on selecting an initial configuration state and then iterating through 
a series of steps during which one or more moves are selected and evaluated for 
acceptance.5 Stochastic conformational searches based on MC-type algorithms are used 
to efficiently sample conformations of the protein chain [154]. MC overcomes energy 
barriers by moving through successive discrete local minima in the energy landscape. In 
this way, MC permits to sample all the minima of conformational space but without 
exploring accurately the higher energy regions [155]. 
Both MD and MC require enhance sampling techniques, described below, to escape from 
energy minima and efficiently reconstruct the underlying free energy landscape.  
 
2.4.3 Enhance sampling techniques.  
Well-converged structural ensembles of IDPs can be obtained on small disordered 
peptides [16-19] by advanced enhance sampling techniques [20,153]. The idea is to 
achieve a random walk in the potential-energy space, which allows the system to easily 
overcome the energy barriers that separate local minima and, therefore, to sample a much 
wider phase space compared to conventional simulations	  [20,153,156].  
Three well-known approaches for carrying out such a “generalized ensemble” MD or MC 
simulations are the multi-canonical algorithm	   [157-159], the simulated tempering	  
[160,161] and the replica exchange method [20,21].  
The multi-canonical algorithm method [157-159] was successfully employed in systems 
that suffer from multiple-minima problem such as spin glasses [162,163]  and in the 
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
5 The number of moves per step is often taken to be the number of available degrees of freedom in that step so as to ensure 
probing (on the average) of each degree of freedom once per step. However, other types of implementations (such as a 
rejection-free algorithm) are also possible. Of particular interest is a class of Monte Carlo simulations that are based on a 
set of pre-defined probabilistic rate constants. 
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protein folding problem [164]. In brief, the method assigns to each state with energy E a 
non-Boltzmann weight that is independent from the temperature, so that a uniform 
potential energy distribution is obtained ensuring that all the energy states are sampled 
with the same likelihood [165]. The flat distribution implies that a free random walk in 
the potential energy space is realized in this ensemble[165]. This allows the simulation to 
escape from any local minimum- energy states and to sample the configurational space 
much more widely than the conventional canonical MC or MD methods [165]. Multi-
canonical methods combined with a trajectory-parallelization method has been also 
developed [166,167] to increase the sampling efficiency still further.  This variant of the 
method has been applied to the coupled problem of the folding and binding of an IPD, 
and it allowed generating the free-energy landscape [168].  
While a simulation in the multi-canonical ensemble performs a free random walk in 
potential energy space, the one employing simulated tempering (ST) approaches performs 
a free random walk in temperature space. This random walk, in turn, induces a random 
walk in potential energy space and allows the simulation to escape from states of local 
energy minima. In ST [160,161], the temperature of the system is randomly switched 
between several predefined values. Both the configuration and the temperature are 
updated during the simulation with a non-Boltzmann weight [157-159]. The frequencies 
of visiting different temperatures depend on the given criteria defining the acceptance 
probability of temperature transitions [160,161]. In the tempering methods, the system 
can frequently visit higher temperatures and go back to lower temperatures with a very 
different configuration [169,170]. ST however requires extensive initial simulations to 
accurately compute the Helmholtz free energy of the system at each temperature 
[169,170]. Moreover, the computational cost of the initial simulations might becomes 
prohibitive in the case of the large configurational space of IDPs [171]. Despite these 
drawbacks, ST was applied, among the others, to study the binding mechanism of two 
IDPs in combination with classical MD [172].  
The former two algorithms (Multi canonical and simulated tempering) make use of non-
Boltzmann probability weight factors, which are not known a priori and need to be 
determined by trial simulations [20,21] [157-159]. This process can be non-trivial and 
very tedious for complex systems with many degrees of freedom.  
In the replica-exchange method, the difficulty of weight factor determination is greatly 
alleviated [156]	  [165]. Replica exchange uses standard Boltzmann weight factors that are 
known a priori [156]. In this method, a number of non-interacting copies (or replicas) of 
the original system at different temperatures are simulated in parallel under different 
conditions [156]; at given time intervals, the simulation conditions are exchanged with a 
specific transition probability between replica pairs [156]. Trajectories at higher 
temperatures are more likely to cross potential energy barriers, leading to a wider array of 
sampled configurations, while trajectories at lower temperatures provide the physically 
relevant acceptance probabilities. Recent applications of the methods to small peptides 
[16-19,21-23] generally confirm that replica exchange can enhance protein 
conformational sampling as long as the activation enthalpies (of conformational 
transitions) are positive. However, the efficacy of replica exchange for IDPs can be 
challenging since the nature of IDPs sub-states and the energy barriers of their inter-
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conversion are not known and the maximum temperature should be carefully estimated 
slightly above where the folding rate maximizes [22,23]. These aspects make problematic 
the choice of simulation key parameters such as the number of replicas, the range and 
distribution of simulation temperatures, and the exchange attempt frequency.  
In this thesis a variant of the replica exchange MD method has been employed to 
characterize the effect of a naturally occurring chemical modification (N-terminal 
acetylation) starting form experimental-derived structures of AS. In particular, I 
employed a variant of the original method, known as replica exchange with solute scaling 
method or REST2 [47,173], in which only the protein and the ions (i.e. the solute) are 
simulated at different effective temperatures by applying an appropriate potential energy 
function to each replica [174]. REST2 [47] is a state-of-the-art efficient sampling method.  
Replica exchange methods could be also coupled with MC simulations (REMC) [14,175] 
[176] to explore the conformation space of IDPs. REMC maintains many independent 
replicas of potential solutions at a different temperature, i.e., protein conformations. At 
any step, each replica locally runs a Markov process sampling from the Boltzmann 
distribution in energy space. At any step, a conformation update involving a change in 
one or more backbone and side-chain torsion angles is proposed, and is either accepted or 
rejected using a Metropolis criterion. A random walk in temperature space is achieved by 
periodic exchanges of conformations at neighboring temperatures [175]. 
New generalized-ensemble algorithms could be obtained by combining the advantages of 
the above three methods (reviewed in [165]).  
Another particularly attractive approach to overcome the sampling bottleneck is to 
combine large numbers of equilibrium and/or generalized ensemble simulations through 
network-like methods based on MC algorithm such as the Markov State Models [177-
179]. This strategy has provided unprecedented details on energy landscapes of several 
proteins under both stable and unstable conditions	   [180-182]. Recently it has been 
applied also to IDPs	  [183,184]. conditions	  [180-182]. Recently it has been applied also to 
IDPs,	  [183,184].  
 
2.4.4 Solvent representation. 
In all the above methods the solvent can be represented either as a continuum model, or 
as a set of macroscopic constants describing the protein-solvent interface and modifying 
the protein-protein interactions [11,185], or through explicit molecules [19,186]. 
Traditional explicit solvent protein force fields arguably provides the most realistic 
description of solvent, but they also significantly increases the system size (~10–fold) 
leading to prohibitive computational costs for sufficiently sampling the immense 
conformational space of IDPs [24]. Moreover, explicit solvent force fields are know to 
have a tendency to over-stabilize helices [26,27] and overestimate the strength of protein-
protein interactions [28].  
A substantial reduction in the computational cost without compromising the essential 
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physics could be reached by employing implicit solvent force fields, where only the 
solute has s full-atom representation [11,187]. The underlying idea of this model is to 
capture the mean influence of water by direct estimation of the solvation free energy 
[11,187]. Recently, important advances have been made to greatly improve the efficacy 
and the achievable accuracy of implicit solvent, particularly with the generalized Born 
(GB) approximation. However, inherent and methodological drawbacks do exist [188]: 
implicit solvent models will not properly describe short-range effects where the detailed 
interplay of a few non-bulk-like water molecules is important and might be further 
limited by the specific methodology employed to calculate the solvation free energy as 
well as the physical parameters of the solvation model [10,189]. Moreover, these 
algorithms over-stabilize non-specific collapsed states [15]. Despite these caveats, the 
implicit force fields have been successfully applied to pKa predictions [190], pH-
dependent protein folding [191-193], structure refinement [194], and recently to 
simulations of regulatory IDPs [79,80] [195,196]. Optimization efforts have also led to 
substantial improvement in other GB models [197,198]. 
 
2.5 THE PROTEIN Α-SYNUCLEIN  
 
Human α -synuclein (AS) is a small natively unfolded protein composed of 140 amino 
acids with a predicted molecular weight of 14,459 Da [199]. The AS protein is 
ubiquitously expressed throughout the brain and is mainly localized at the presynaptic 
terminal [200,201]. It is a major constituent of Lewy bodies	  [202], protein clumps that are 
the pathological hallmark of Parkinson’s disease (PD) (see Appendix A). AS may 
contribute to PD pathogenesis in a number of ways, but it is generally thought that its 
aberrant soluble oligomeric conformations, termed protofibrils	  [203], are the toxic species 
that mediate disruption of cellular homeostasis and neuronal death, through effects on 
various intracellular targets, including synaptic function	  [204,205]. 
The amino acid sequence can be divided into three regions, with each region having 
distinct structural characteristics. The highly conserved N-terminal region encode for a 
series of six imperfect 11 amino acid repeats with a consensus motif of KTKEGV, 
predicted to resemble the lipid-binding domain of apolipoprotein, containing several 
amphipathic helices [206,207]. The N-terminal domain binds to phospholipids and may 
adopts an a-helical conformation suggesting that the biological function of AS may 
involve binding to lipid membranes [208]. The central region, referred to as the non 
amyloid-like component (NAC region) was originally isolated is association with the Ab 
peptide in Alzheimer’s disease amyloid plaques [209]. This region is hydrophobic and 
contains the amino acid sequences essential for b-sheet amyloid fibril formation [210]. 
The acidic C-terminal region of AS contains mostly negatively charged residues and is 
largely unfolded, which has been implicated in regulating its nuclear localization and 
interactions with metals, small molecules and proteins [211]. 
Several studies suggest that native AS exists in equilibrium between 3 different 
conformational and/or oligomeric states [49]: unstructured monomeric forms that 
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predominate in solution, a set of semi-structured forms, soluble multimers, at low 
concentration, referred to as a protofibrils and insoluble amyloid fibrils, which coalesce to 
form aggregated protein inclusions in the cytosol of surviving neurons, the Lewy bodies 
[202,212]. The latter are the key neuro-pathological feature in brains of PD patients	  
[213]. In contrast to the rapid equilibrium between disordered and semi-structured AS 
monomers, the equilibrium between monomeric and multimeric states is quite slow, 
owing to the slow rate of dissociation of monomers from the oligomeric state	  [214]. Thus, 
multimeric AS aggregates are present at low concentrations, but have a comparatively 
long half life, and can explore a variety of conformations during their lifetime[215]. 
Multimeric forms can be stabilized on a phospholipid bilayer, and that association with 
the membrane can lead to membrane penetration[215]. 
Several factors, including oxidative stress	   [216], post-translational 
modifications[217,218], such as acetylation [219], proteolysisand the concentrations of 
fatty acids	   [220-223], were shown to induce and/or modulate AS structure and 
oligomerization in vitro, and these factors may influence this equilibrium between the 
monomer and oligomer state in vivo	   [203]. So far, it has been established that the 
conformational properties of AS are thought to play a key role in the structural transition 
from the monomer to amyloid fibrils[45].  
The biological role of AS is not fully understood	   [224]. There are strong evidences 
suggesting that AS is involved in regulating and maintaining DOP homeostasis within the 
cytoplasm [35]. AS act as a negative regulator of DOP biosynthesis by interacts with 
tyrosine hydroxylase and reduces the activity of this enzyme [35]  
Understanding how structural factors and environmental conditions predispose AS to 
aggregate into multimeric structures is of critical importance in understanding disease 
first step progression. Gaining this knowledge will also have important implications for 
the development of therapeutic strategies based on targeting AS [225].
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CHAPTER 3	  
	  
	  
	  
	  
	  
3. MATERIALS AND METHODS 
	  
Computer simulation methods have become a very powerful tool to study many-body 
problems in statistical physics, physical chemistry and biophysics. Although the 
theoretical description of complex systems in the framework of statistical physics is 
rather well developed and the experimental techniques for detailed microscopic 
information are rather sophisticated, it is often only possible to study specific aspects of 
those systems in great detail via the simulation. On the other hand, simulations need 
specific input parameters that characterize the system in question, and which come either 
from theoretical considerations or are provided by experimental data. Having 
characterized a physical system in terms of model parameters, simulations are often used 
both to solve theoretical models beyond certain approximations and to provide a hint to 
experimentalists for further investigations. In the case of big experimental facilities it is 
even often required to prove the potential outcome of an experiment by computer 
simulations.  
This chapter is divided in two paragraphs. The first describes the theoretical background 
of classical molecular dynamics. Classical molecular dynamics simulations were 
employed in this thesis as an exploratory tool to investigate the system of alpha-synuclein 
(AS) in adduct with dopamine (DOP), and at the same time as a tool to discover new 
insights on the system through the measurement of specific properties. In the second 
paragraph replica exchange molecular dynamics method is described. It was used in this 
thesis to explore the conformational space of N-acetylated alpha-synuclein protein.  
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3.1 CLASSICAL MOLECULAR DYNAMICS 
	  
3.1.1 Introduction 
Molecular dynamics (MD) simulations are important tools for understanding the physical 
bases of the structure and function of biological macromolecules, since the study of the 
internal motions and resulting conformational changes play an essential role in their 
function. 
It has been 35 years since the first classical molecular dynamics simulation of a 
macromolecule of biological interest was published [226]. Classical MD simulation is a 
technique for computing the equilibrium and transport proprieties of classical many-body 
systems. The basic assumption of classical MD is that the classical mechanics Newton’s 
equation of motion can be used to describe the motions of atoms and molecules; therefore 
quantum mechanical effects are not taken into account explicitly.  
Theoretically, this assumption holds when atoms and molecules can be correctly 
described within the Born-Oppenheimer approximation [227], where the nuclei move 
according to the laws of classical mechanics and the electrons follow them 
instantaneously. The notion of ‘atoms in molecules’ is only an approximation of the 
quantum-mechanical picture, in which molecules are composed of interacting electrons 
and nuclei. Electrons are to a certain extent delocalized and ‘shared’ by many nuclei and 
the resulting electronic cloud determines chemical bonding. It turns out, however, that to 
a very good approximation, known as the adiabatic (or Born–Oppenheimer) 
approximation, based on the fact that the mass of the nuclei is much larger than the mass 
of the electrons, the electronic and nuclear problems can be separated. The electron cloud 
‘equilibrates’ quickly for each instantaneous (but quasi-static on the time scale of 
electronic motions) configuration of the heavy nuclei. The nuclei, in turn, move in the 
field of the averaged electron density.  
As a consequence of the separation of the electronic and nuclear variables, one may 
introduce the notion of the potential energy surface, which determines the dynamics of 
the nuclei without taking explicit account of the electrons. Hence there is no need to 
model the electrons explicitly and it is sufficient to account for their average effect by an 
analytical interaction potential among the nuclei. The problem of finding a realistic 
empirical potential that would adequately mimic the true energy surfaces is nontrivial but 
it leads to tremendous computational simplifications. 
Given the potential energy surface, it is possible to use classical mechanics to describe 
the dynamics of the nuclei. Identifying the nuclei with the centers of the atoms and the 
adiabatic potential energy surface with the implicit interaction law among the atoms, a 
rigorous justification of the intuitive representation of a molecule in terms of interacting 
atoms is therefore obtained.  
Beyond Newton’s equations of motion, classical MD methods can be alternatively 
described through the Hamiltonian function of the system and the corresponding 
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Hamilton's equations of motion.  
Classical MD simulations generate information at microscopic level, in particular 
providing atomic positions and velocities as a function of time, i.e. the complete 
description of the system in the sense of classical mechanics. Therefore, MD simulations 
permit to probe both the configuration space and the whole phase space of the system.  
The microscopic information has to be translated into macroscopic observables like 
pressure, heat capacities, and diffusion coefficients, by means of statistical mechanics.   
Preparing a classical MD simulation is like preparing an experiment.  Particle simulations 
require three basic ingredients:  
• A model for the interaction between system constituents. This model has to be 
tested again experimental results. Often, it is assumed that particles interact only 
pair wise. This assumption reduces the computational effort.  
• An integrator, which propagates particles positions and velocities from time t to 
t+δt. It is a finite difference scheme that moves trajectories discretely in time.  
• A statistical ensemble, where thermodynamic quantities like temperature, 
pressure and number of particles are controlled. The natural choice for the 
ensemble is the microcanonical one (NVE), since the Hamiltonian of the system 
is a conserved quantity if external potentials are not present. Nevertheless, there 
are extensions to the equations of motion that also allow one to simulate different 
statistical ensembles and that are very important in biophysics. 
A classical MD algorithm can be summarized in the following steps:  
1. Defining the initial conditions (position and velocities of all the particles in the 
system) and the potential energy function depending on the atomic positions 
(system setup) 
2. Computing the forces acting on each atom. 
3. Solving numerically the Newton’s or Hamilton’s equations of motion, i.e. 
updating the system configuration at a certain time t to the one at a time t + δt, 
where δt is the time step. 
4. Writing the new positions, velocities, energies, etc. 
5. Back to point 2. until the proprieties of the system on average no longer change 
in time. 
6. Performing the post-processing data analysis. 
Thus, when one can provide a good guess for the initial positions of the atoms (by 
experiments or by computer modeling) and an initial distribution of velocities, then the 
accelerations are determined by the gradient of the potential energy function and the time 
evolution of the system can be obtained.  
In the MD simulations performed in the ‘production run’, the initial coordinates for a 
classical MD simulation usually comes from preliminary equilibration steps such as an 
energy minimization (where a set of coordinates is found that minimizes the total energy 
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of the system and that satisfies any given constrain) and a gradual heating (which bring 
the temperature of the system gradually to the target temperature).  
When the initial temperature is not zero, the initial velocities are usually randomly 
generated at the beginning of the simulation only constraining them to satisfy the 
Maxwell distribution at that temperature.  
The force acting on each particle is calculated by using a specific potential energy 
function or “force field” and the atomic positions of all the other particles. Any modern 
force field is formed by two kinds of terms, very different from the computational point 
of view: the ones involving short-range interactions and the one involving long-range 
interactions. The short-range interaction terms represent those physical interactions that 
become negligible when the particles come far apart. Therefore, to save computational 
time, these terms are usually evaluated only for particles that are within a certain fixed 
cutoff distance.  
The equations of motion are solved by some finite difference integration method and 
finally the configuration of the system is updated. The entire cycle just described is 
indefinitely repeated to produce the MD trajectory, with the only difference that the initial 
coordinates and velocities at each step are the updated coordinates and velocities from the 
previous step.   
In this work, the NAMD simulation package [228] has been used to run the classical MD 
simulations.  
In the following sections, the above-mentioned basic ingredients of a classical MD 
simulation are described in more details.  
3.1.1.1 Equation of motion 
In classical MD simulations the time evolution of a set of interacting particles is usually 
calculated by numerically solving the Newton’s equations of motion of the particle 
system. For a system of N point particles of mass mi (i=1,…,N) at position ri(t)=(xi(t), 
yi(t), zi(t)) and velocity vi(t) they are given by 
 
Fi = mi
d 2ri (t)
dt 2       (3.1) 
where Fi is the force acting upon i-th particle at time t, obtained from the potential energy 
of the system U(r1,r2,…,rN) via the equation: 
 
Fi = !"riU({r}) = !
#U
#xi
, #U
#yi
, #U
#zi
$
%&
'
()
                                    (3.2) 
Solving Eqs. (3.1) once given the initial conditions ri(t0) and vi(t0) at a certain time t0, 
provides the complete information of the motion of a system. 
‘Particles’ usually correspond to atoms, although they may represent any distinct entities 
(e.g. specific chemical groups) that can be conveniently described in terms of a certain 
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interaction law.  
Alternatively, Hamilton’s equations of motion for the (generalized) momenta pi and 
positions ri can be used to calculated the time evolution of the system: 
 !ri = ! pi H        !pi = !ri H        (3.3) 
where H is the Hamiltonian of the system: 
 
H = pi
2
2mii=1
N
! +U({r})
    
(3.4) 
In Cartesian coordinates Hamilton’s equations become 
   
!ri =
pi
mi                                                        (3.5)
 
                                        !pi = !"riU({r}) = Fi
              
 
Due to the complexity of the many-body problem, the only feasible way to solve Eqs. 
(3.1) when N > 2 is by discretizing the time and solving them numerically through a 
computer.  This means that the positions and velocities are propagated with a finite time 
interval using numerical integrators, such as the Verlet algorithm (see later). The position 
of each particle in space is defined by ri(t), whereas the velocities vi(t) or the momenta 
pi(t) are used to get the kinetic energy and temperature in the system. As the particles 
‘move’, their trajectories may be displayed and analyzed, providing averaged properties. 
The dynamic events that may influence the functional properties of the system can be 
directly traced at the atomic level, making MD especially valuable in molecular biology. 
 
3.1.2 Models for particle interaction 
All simulated objects are defined within a model description. A mechanical system is 
completely determined through its Hamiltonian H = H0 + H1, where H0 is the internal part 
of the Hamiltonian, given by 
 
H0 =
pi
2
2mii=1
N
! + u(ri , rj ) +
i< j
N
! u(3) (ri , rj , rk )
i< j
N
! + ...    (3.6)  
where u and u(3) are pair and three-body interaction potentials, and the series could be 
extended with more and more multi-body interaction terms. H1 is the external part, which 
can include time dependent effects or external sources of forces. Often a precise 
knowledge of the interaction between atoms, molecules or surfaces are not known or are 
too complex to be efficiently calculated, and model terms are then constructed in order to 
describe the main features of some observables.  
In classical MD simulations the entities are most often described by point-like centers 
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that interact through pairs or multi-body interaction potentials. In that way the highly 
complex description of electrons and nuclei dynamics is abandoned and an effective 
picture is adopted where the main features like the hard core of a particle, electric multi-
poles or internal degrees of freedom of a molecules are modeled by a set of parameters 
and analytical functions which depend on the mutual position of particles in the 
configuration. Since the parameters and functions give complete information of the 
potential energy U of the system as well as the force acting on each particle through Eqs. 
(3.2), the combination of parameters and functions is also called a force field. U is 
therefore built as an empirical quantity. Hence, there is no correct functional form: it is 
rather a compromise between accuracy and efficiency. Different types of force fields 
were developed during the last ten years: among them, the CFF95[229], AMBER[230], 
CHARMM[231], OPLS[232] and MMFF[233] force field.  
In this work the Amber parm99SB force field [29] with ildn modification [37,38] was 
employed. 
Potential interaction terms in a force field can be classified according to their major 
differences. The first important distinction is made between pairs and multi-body 
potentials. In systems with no constraints, the interaction is most often described by pair 
potentials, which is simple to implement into a program. In the case where multi-body 
potentials come into play, the counting of interaction partners becomes increasingly more 
complex and dramatically slows down the execution of the program. Only for the case 
where interaction partners are known in advance, e.g. for torsional or bending motions of 
a molecule, the interaction can be calculated efficiently by using neighbor lists or by an 
intelligent way of indexing the molecular sites. 
A second important difference among interaction terms is the spatial extent of their 
action, classifying them into short- and long-range interaction terms. If the potential term 
drops down to zero faster than rd when the separation r between two particles becomes 
larger and larger (d is the dimension of the problem), the interaction is called short-
ranged otherwise it is long-ranged. The reason for these names becomes clear by 
considering the integral 
(3.7) 
It tells that the potential energy would get contributions from all particles of the universe 
if n ≤ d, while the interaction can be bound to a certain region if n < d, and it is often 
modeled by a spherical interaction range. The long-range nature of the interaction 
becomes most important for potentials that only have potential parameters of the same 
sign, like the gravitational potential where no screening can occur. For Coulomb energies, 
where positive and negative charges may compensate each other, long-range effects may 
be of minor importance, as for example in some systems like molten salts. However, this 
is not the case in the most applications in biophysics as we will see in the next sections. 
In the following, the different treatment of short and long-range interactions are 
illustrated. 
 
I = dr
d
rn =!
" :n # d
finite :n > d
$
%
&
'&
(
)
&
*&
	  	  
26	  
U(r1,…rN ) =
ai
2 (li ! li0 )
2
bonds
" + bi2 (!i !!i0 )
2
angles
" + ci (1+ cos(n(!i !!i0 )))+ ...
torsions
"
+ 4" ij
# ij
rij
#
$%
&
'(
12
!
# ij
rij
#
$%
&
'(
6)
*
+
+
,
-
.
.atoms
pairs
" + k qiqjrijatoms
pairs
"
3.1.2.1 Atomic force field model of molecular systems  
The atomic force field model describes physical systems as collections of atoms kept 
together by interatomic forces. In particular, chemical bonds result from the specific 
shape of the interactions between atoms that form a molecule. 
Atomic force field models and the classical MD are based on empirical potentials with a 
specific functional form, representing the physics and chemistry of the systems of 
interest. The adjustable parameters are chosen such that the empirical potential represents 
a good fit to the relevant regions of the ab initio Born–Oppenheimer surface, or they may 
be based on experimental data. The functional form of the potential energy used in the 
simulations is usually expressed as a sum of four terms: 
                                                                             (3.8) 
that is: 
 
 
                                                                                                                                        (3.9) 
 
 
In the first three terms summation indices run over all the bonds, angles and torsion 
angles defined by the covalent structure of the system, whereas in the last two terms 
summation indices run over all the pairs of atoms (or sites occupied by point charges qi), 
separated by distances rij= |ri-rj| and not bonded chemically. Physically, the first two 
terms, the bond-stretching UBL and the bond-bending UBA, describe energies of 
deformations of the bond lengths li and bond angles θi from their respective equilibrium 
values li0 and θi0. The harmonic form of these terms (with force constants ai and bi) 
ensures the correct chemical structure, but prevents modeling chemical changes such as 
bond breaking. The third term Utorsion, is the torsion potential for amino acid side chains. 
It describes rotations around the chemical bonds, which are characterized by periodic 
energy terms, with periodicity determined by n and the parameters of the fit that represent 
the force constraints (heights of rotational barriers) defined by ci. The expression of this 
term reported in the Eq. (3.9) is the torsion potential optimized in the ff99sb force field 
with the ildn modification [37,38]. 
The fourth term Unonbond, is the non-bonded potential term. As the name implies, non-
bonded interactions act between atoms in the same molecule (distant more than three 
bonds in the connectivity) and those in other molecules, which are not linked by covalent 
bonds. The force field divide non-bonded interactions into two terms: the first takes into 
account the van der Waals repulsive and attractive (dispersion) interatomic forces in the 
form of the Lennard–Jones potential, and the last term is the Coulomb electrostatic 
potential. Some effects due to specific environments can be accounted for by properly 
adjusted partial charges qi (and an effective value of the constant k) as well as the van der 
Waals parameters eij and sij. In the next subsections, the methods to calculate the Unonbond  
U =UBL +UBA +Utorsion +Unonbond
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terms are described. 
3.1.2.2 Short-Range Interactions 
Short-range interactions allows one to take into account only neighbored particles up to a 
certain distance for the estimation of interactions, i.e. a cutoff radius is introduced beyond 
of which mutual interactions between particles are neglected. To upgrade accuracy one 
may introduce long-range corrections to the potential in order to compensate the fact that 
the interactions beyond the cutoff are neglected in the calculation. The whole short-range 
potential may then be written as 
 
   (3.10) 
The long-range correction is usually approximated as  
            (3.11) 
where ρ0 is the number density of the particles in the system and g(r) = ρ(r)/ρ0 is the 
radial distribution function. For computational reasons, g(r) is most often only calculated 
up to Rc, so that in practice it is assumed that g(r) = 1 for r > Rc, which makes it possible 
for many types of potentials to calculate Ulrc analytically. The equation above implies that 
the tail contribution to the potential energy diverges, unless the potential energy u(r) 
decays faster than r-3. Therefore, as already seen above, it is possible to apply the 
truncation method for short-range interactions as the van der Waals term which decays as 
r-6, but not for long-range interactions as the Coulomb term which decays as r-1. 
Besides the internal degrees of freedom of molecules, which may be modeled with short-
range interaction potentials, it is the excluded volume of a particle that is relevant at short 
distances. A finite diameter of a particle may be represented by a steep repulsive potential 
acting at short distances. This is either described by an exponential function or an 
algebraic form proportional to r-n with n≥9. Another source of short-range interaction is 
the van der Waals interaction. For neutral particles this comes from the London forces 
arising from induced dipole interactions: fluctuations of the electron distribution of a 
particle give rise to fluctuating dipole moments, which on average compensate to zero. 
But the instantaneous dipoles induce also dipoles on neighbored particles that attract each 
other with a law proportioanal to r-6. Two common functional forms have been used to 
describe these two last contributions to the short-range interactions: the Buckingham 
potential 
       (3.12) 
and the Lennard-Jones potential 
Usr = u rij | rij < Rc( )+Ulrc!
Ulrc = 2!N"0 drr2g(r)u(r)
Rc
#
$
u!"B (rij ) = A!"e#B!" rij #
D!"
rij6
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                 (3.13) 
The indices α,β indicate the species of the particles, i.e. there are different parameters 
A,B,D in Eq. (3.12) and ε,σ in Eq. (3.13) for intra-species interactions (α=β) and cross 
species interactions (α≠β). For the Lennard-Jones potential the parameters have a simple 
physical interpretation: ε is the minimum potential energy, located at r = 21/6σ and σ is 
the diameter of the particle, since for r < σ the potential becomes repulsive. Often the 
Lennard-Jones potential gives a reasonable approximation of a true potential.6 The 
Lennard-Jones potential has another advantage over the Buckingham potential: 
“combining rules” for cross species parameters from inter species ones. For Amber force 
fields, cross terms involving different atom types α and β are evaluated according to the 
Lorentz-Berelot combining rule:  
 ,     (3.14) 
This combining rule is, however, known to overestimate the well depth parameter.  
In this thesis the Lennard-Jones functional form has been adopted. Typically, a cutoff 
radius of the order of 10 Å is used for this kind of interactions. 
3.1.2.3 Neighbors list 
The computation of the short-range van der Waals terms involve, in principle, a large 
number of pairwise calculations. However, only a relatively small number of pairs are 
within the cutoff radius for the van der Waals interactions. Therefore, in order to speed up 
the simulation, a neighbor list strategy is commonly employed.  
Namely, in a system composed of N atoms, for each atom i the distances with the 
remaining N-1 atoms are calculated once every a certain number of steps. The short-range 
non-bonded contribution to the total force acting on i is due only to the atoms within a 
sphere of a certain radius Rc from the atom i. A list of all of the atoms that are at a 
distance smaller than Rc  + Δ list is created for each atom i, where Δ list is a value chosen by 
the user (typically ≈ 1–2 Å) and that is introduced since the list will be updated only after 
a certain number of steps. At each time step within two consecutive creations of neighbor 
lists, the search for the atoms situated at a distance smaller than Rc of a given atom is done 
only over the atoms included in its neighbor list. The list is updated regularly but only 
after a certain number of steps (e.g. 20) to take into account the atoms that enter or leave 
the sphere.  
 
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
6 However, more accurate quantum mechanical calculations show that an exponential repulsive type potential is often more 
appropriate. Especially for dense systems, the too steep repulsive part of the Lennard-Jones potential, proportional to r-12, 
often leads to an overestimation of the pressure in the system. Therefore, since computationally the Lennard-Jones 
interaction is quite appealing the repulsive part is sometimes replaced by a weaker repulsive term, like ∝ r-9.  
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3.1.2.4 Periodic boundary conditions 
In most cases simulations are not aimed to study isolated (in vacuo) particles, but bulk 
properties of a liquid or solid system. In particular, due to the importance of water in 
connection with the properties of biological macromolecules, these systems are 
commonly simulated in aqueous solution rather than in gas phase.  
However, standard simulations can track only a small number of particles in order not to 
slow down the computation. As a result, in these conditions most molecules would be 
near the edge of the system, resulting in unrealistic surface effects. 
To overcome the problem of surface effects, periodic boundary conditions (PBC) are 
usually employed. Typical biomolecular simulations use therefore PBC to avoid surface 
artifacts and mimic the properties of bulk systems. In this approach, the system is 
surrounded with replicas of itself in all directions, to yield an infinite periodic lattice of 
identical cells. Only the N atoms inside the main cell are considered explicitly, but as 
soon as one of the atoms leaves the cell, an image particle enters from the opposite side to 
replace it. 
Whether the system should interact with its periodic replicas or not depends on the nature 
of the interaction. For the short-range interaction, if the potential range is not too long 
(the cutoff radius do not exceed half of the box size), then the Minimum Image 
Convention can be adopted in the calculation of short-range terms. In fact, in this 
condition it can be proved that to calculate the interaction contribution of particles i and j 
in the box only the closest image of particle j to i, among the infinite periodic replicas, 
has to taken into account. 
In the case of macromolecules simulated in solution, the interactions of the 
macromolecules with their periodic images would be an artifact and should be avoided. 
Thus, a common rule of thumb is to build a water box around the solute such that the 
length of each box vector must exceed the length of the macromolecule in the direction of 
that edge plus twice the cutoff radius. 
3.1.2.5 Long-Range Interactions 
The treatment of long-range interactions, as the Coulomb interaction, is related to the 
choice of boundary conditions imposed on a system to deal with its finite size and surface 
effects. The two common approaches are based on either periodic boundary condition and 
an Ewald method or on spherical boundary conditions and a reaction field method. 
Having chosen PBC, in this thesis we employed the first approach.  
As we have seen previously, in the case of long-range potentials no cutoff approximations 
can be used (cf. Eq. (3.11)). Therefore, interactions between all particles in the system 
must be taken into account. This leads to an O(N2) problem, which increases considerably 
the execution time of a program for large systems. For systems with open boundary 
conditions (like liquid droplets), this method is straightforwardly implemented and 
reduces to a double sum over all pairs of particles but for PBC a more sophisticated 
technique (Ewald approach) is usually employed. 
The total Coulomb energy of a system of N particles in a L box size, in the case when 
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PBC are applied, must take into account not only the interactions with particles in the 
central cell but also with all periodic images and formally it can be written as the 
following lattice sum: 
Ucoulomb =
1
2 '
qiqj
| rij + nL |n!i, j=1
N
!               (3.15) 
where n =(n1, n2, n3)=n1Lx+n2Ly+n3Lz is a lattice vector (x, y, z are the unit vectors 
along the Cartesian axes) and  means that for n = 0 the sum runs over i ≠ j, 
|rij+nL|=|ri-rj+nL| is the distance between the particle i in the origin cell and the particle 
j in the image cell identified by the vector n. It is, however, a well-known problem that 
this type of lattice sum is conditionally convergent, i.e. the result depends on the order in 
which the terms are summed.  
A method to overcome those limitations was invented by Paul Peter Ewald in 1921 [234]. 
For simulations of proteins and enzymes in a crystalline state, the Ewald summation is 
considered to be the best treatment for long-range electrostatic interactions [235].  
In the Ewald method the charge distribution ρ(r) of the system is represented by an 
infinite set of point charges qi that can be written in terms of delta function as: 
 !i (r) = qi" (r # ri + nL)                                                  (3.16) 
The idea behind the method is to surround every point charge by an isotropic Gaussian 
charge distribution of equal magnitude and opposite sign: 
 
!i
G (r) = qi
"
#
$
%&
'
()
3
2 e*" |ri +nL |2
            
(3.17)  
where α is an arbitrary parameter adaptable to optimize the speed of convergence. This 
extra distribution acts like an ionic cloud, to screen the interaction between neighboring 
charges, so that the screened charge distribution becomes short-range and the total 
screened potential, formed by these two terms, is calculated summing over all molecules. 
A charge distribution of the same charge as the distribution ρG but opposite sign is then 
added in order that the total charge of the system remains equal to the original one. The 
resulting total charge distribution can be written as: 
 
!(r) = qi" (r # ri + nL)
i
$
 
= [qi! (r " ri + nL)
i
# " $iG (r)]+ $iG (r)
i
#  .     (3.18) 
In order to exclude self-interactions deriving by the fact that we considered point-like 
particles, the contributions of these three charge densities should not be evaluated at ri. 
However, it is convenient to keep self-interactions due to the canceling charge 
distribution ρG (the last term in Eq. 3.18) since it is in this way periodic and can be 
represented as a rapidly converging Fourier sum in the reciprocal space. The spurious 
n '!
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self-interactions can be easily subtracted separately at the end. 
The first sum in the Eq. (3.18) corresponds to the term in the potential expression that is 
calculated in the direct space, while the second is calculated in the reciprocal space. The 
evaluation of Ucoulomb thus splits into three different terms: 
Ucoulomb =Ureal +Ureciprocal +Uself              (3.19) 
The first two sums, however, depend on the inter-particle separations rij, which need to be 
evaluated at each time step. Therefore, the lattice sum is essentially split into a sum which 
is evaluated in real space and a sum over the reciprocal space vectors, k = 2πn/L. 
The first term in (3.19) gives the potential of a set of point charges that are screened by an 
opposite charge of the same magnitude but with a Gaussian form factor with the width of 
the Gaussian given by α: 
 
Ureal =
1
2 '
qiqj
| rij + nL |n!
erfc( " | rij + nL |)
i, j=1
N
!    (3.20)  
Ureal is very similar to Eq. (3.15) although contains mainly short-range contributions since 
the long ranged 1/r function is here substituted by the short ranged erfc(r)/r, where 
,     (3.21) 
is the complementary error function which decays to zero as e-x^2 for large x [236]. As a 
result, the interaction vanishes above a cutoff roughly equal to α−1/2, and for each pair of 
particles i and j the interaction can be approximated by only one periodic image term. 
Typically, α is chosen such that the truncation error is of the order of 10−5 - 10−6 of Ureal 
so that to justify the limitation to the central simulation cell only for the evaluation of the 
real space sum. 
In contrast, the second term in (3.19) contains mainly long-range contributions. 
Therefore, the sum is better evaluated in reciprocal space: 
 
Ureciprocal =
4!
2L3
1
k2k"0# qiqji, j=1
N
# e$
k2
4% eikrij           (3.22) 
Ureciprocal is in principle a sum over an infinite number of terms, but the factor exp(-k2/4α)  
ensures a fast convergence in the reciprocal space for large k-vectors, and normally no 
more than 5-10 wave vectors in each direction are required. Its calculation is however the 
most consuming part in the Ewald scheme.  
The Uself  term is constant and may be calculated at the beginning of the simulation:  
erfc(x) =1! 2
!
e!u2 du
0
x
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(3.23)  
Uself is the self-interaction of the Gaussian charge distributions: it must be subtracted from 
the total, as the reciprocal space term Ureciprocal contains it, albeit it is a constant number, 
not depending on the atomic configuration. 
3.1.2.6 Particle Mesh Ewald 
The approximated but numerically faster variation of the Ewald summation method 
named the particle-mesh Ewald method (PME) [237] is employed in the NAMD program 
and used in this thesis. 
The PME approach allows a fast calculation of the electrostatic energy in PBC, using the 
great advantages of the fast Fourier transform (FFT) for calculating discrete Fourier 
transforms. When a fixed cutoff is applied to the direct Ewald sum, the number of terms 
needed in the reciprocal sum scale with O(N). Since each such term is nominally of order 
of N to calculate, the reciprocal sum is O(N2). Similarly, the discrete Fourier transform of 
N coefficients is an order of N2 calculation. However, the FFT performs this task in 
O(NlogN) operations. Therefore, the PME algorithm is particularly suited to simulate 
Coulombic electrostatic interactions of periodic systems with a large number N of atoms. 
In the paragraph below is described the case. 
 
3.1.3 Integration of the equations of motion  
For a given potential model that characterizes the physical system, the integrator is 
responsible for the accuracy of the simulation results. If the integrator would work 
without any error the simulation would provide exact model results within the errors due 
to a finite number representation. However, any finite difference integrator is an 
approximation for a system evolving continuously in time. An integrator has to be 
therefore: 
- accurate, in the sense that it approximates the true trajectory very well (this may be 
checked with simple model systems for which analytical solutions exist) 
- stable, in the sense that it conserves the total energy when evolves an isolated system 
and that small perturbations do not lead to instabilities 
- robust, in the sense that it allows for large time steps in order to propagate the system 
efficiently through phase space. 
An integrator for Newton’s equations of motion can be defined by the expression that 
provides the positions ri(t+δt) and possibly the velocities vi(t+δt) at time t+δt in terms of 
the positions at previous time t. The integration time step δt is chosen at the beginning of 
the simulation and it remains unchanged during the run. The time step must be small 
enough to allow describing the fastest motions of the system. Bonds involving light 
atoms (e.g. the O–H bond) vibrate with periods of several femtoseconds, implying that δt 
should be on a sub-femtosecond scale to ensure stability of the integration: δt ≤ 0.5 fs is 
Uself =
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normally used when bonds involving hydrogens are allowed  stretching. However, bond 
stretching is of little interest in most cases, therefore bonds are constrained to their 
equilibrium lengths using SHAKE [238], as in this thesis, or LINCS [239] algorithms. In 
this way, a time step up to 2 fs can be employed while still preserving a good accuracy.7 
The simplest and most straightforward way to construct an integrator is by expanding the 
positions and velocities through a Taylor series. The class of integrators which may be 
obtained in that way are called Störmer-Verlet integrators. The most used algorithms for 
the integration of the equations of motions are the so-called original and velocity Verlet 
[240], and Leap-Frog [241] algorithms.8.  
To derive the original Verlet algorithm we start with the Taylor expansion of the position 
and velocity of a particle around the time t for a small enough time step δt: 
 
r(t + !t) = r(t) + dr(t)dt !t +
1
2!
d 2r(t)
dt 2 !t
2 +
1
3!
d 3r(t)
dt 3 !t
3 +…       (3.24) 
Velocities can be calculated numerically from the positions as the first order derivatives 
or propagated explicitly as in the Leap-Frog or velocity Verlet [240] schemes: 
 
v(t + !t) = v(t) + dv(t)dt !t +
1
2!
d 2v(t)
dt 2 !t
2 +
1
3!
d 3v(t)
dt 3 !t
3 +…      (3.25) 
Eq. (3.24) is accurate up to terms of the fourth power in δt.  
In the same way the expansion may be performed for δt ->-δt, which gives 
 
r(t ! "t) = r(t) ! dr(t)dt "t +
1
2!
d 2r(t)
dt 2 "t
2 !
1
3!
d 3r(t)
dt 3 "t
3 +…   (3.26) 
 
v(t ! "t) = v(t) ! dv(t)dt "t +
1
2!
d 2v(t)
dt 2 "t
2 !
1
3!
d 3v(t)
dt 3 "t
3 +…   (3.27) 
The first order derivative of r(t)  with respect to t is equal to the velocity v(t). Similarly, 
the second order derivative equals to the acceleration a(t), which can be substituted by the 
force according to the Newton’s second law.  
Adding up Eq. (3.24), (3.25) and (3.26), (3.27) gives for the new positions and velocities: 
 r(t + !t) = 2r(t) " r(t " !t) + a(t)!t
2 +O(!t 4 )                     (3.28) 
 
v(t + !t) = 2v(t) " v(t " !t) + d
3r(t)
dt 3 !t
2 +O(!t 4 )       (3.29) 
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
7 A time step of more than 5 fs can rarely be achieved in stable simulations of biomolecules. 
8 The Leap-Frog algorithm remedies to the lack of the original Verlet algorithm that does not allow the velocities to be 
explicitly calculated [242]	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An integration method whose truncation error is of order of δt(n+1) is called an n-th order 
method. The last equations are therefore of 3rd order. The drawback of eq. (3.29) is, 
however, that it requires the 3rd derivative of the coordinates with respect to time that is 
not routinely calculated in MD simulations and thus introduces some additional 
computational and storage overhead. To overcome this drawback one can simply 
substract Eq. (3.26) from Eq. (3.24), giving the central difference scheme for the velocity 
 
v(t) = 12!t r(t + !t) " r(t " !t)( ) +O(!t
3)          (3.30) 
This is, however, one order smaller in accuracy than Eq. (3.29) and it provides velocities 
at the time step t, not at t + δt. Since the information about v(t) is not required by Eq. 
(3.28) to calculate accurately the positions, one may take Eq. (3.30) as an estimate for the 
velocities from which the kinetic energy of the system is calculated. 
The original Verlet algorithm described above, from the point of view of storage 
requirements is not optimal, since Eq. (3.28) and (3.30) require positions not only at time 
t but also at time t-δt. An equivalent algorithm, which stores only information from one 
time step is the so called velocity Verlet algorithm: 
     
r(t + !t) = r(t) + v(t)!t + 12 a(t)!t
2    (3.31) 
 
v(t + !t) = v(t) + 12!t a(t) + a(t + !t)( )   (3.32) 
This scheme, however, requires the knowledge of the accelerations at time step t+δt. 
More accurate velocities can be obtained with the Verlet Leap-Frog algorithm, adopted in 
this thesis, which uses velocities at half time step. One may therefore decompose Eq. 
(3.32) into two steps. First one calculates 
 
v(t + !t / 2) = v(t) + 12 a(t)!t     (3.33) 
then he computes the actual forces on the particles at time t+δt, having already calculated 
the new position through Eq. (3.31), and finishing the velocity calculation with 
 
v(t + !t) = v(t + !t / 2) + 12 a(t + !t)!t           (3.34) 
At this point the kinetic energy may be calculated without a time delay of δt, as it was in 
Eq. (3.30). The Leapfrog algorithm has some advantages over the original Verlet 
algorithm (Eq. 3.30). First, the loss of accuracy due to round-off error in the original 
Verlet algorithm because of vastly different magnitudes of terms in the equation is 
corrected. Second, the velocities are included explicitly in the method, unlike the original 
Verlet algorithm.  
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3.1.4 Molecular Dynamics As a Statistical Mechanics Method 
	  
3.1.4.1 Calculating averages from a molecular dynamics simulation 
Macroscopic properties measured in an experiment such as pressure, energy, heat 
capacities, etc., are averages over billions of molecules since an experiment is usually 
made on a macroscopic sample that contains an extremely large number of atoms or 
molecules sampling an enormous number of conformations.  
MD simulations generate information at microscopic level (including atomic positions 
and velocities or momenta). The connection of this microscopic information from MD to 
macroscopic observables is provided by statistical mechanics. In statistical mechanics, 
averages corresponding to experimental observables are defined in terms of ensemble 
averages. An ensemble average is an average taken over a large number of replicas of the 
system considered simultaneously. 
The set of atoms’ coordinates and momenta can be thought as coordinates in a 
multidimensional space: the phase space. For a system of N atoms, this space has 6N 
dimensions. Let us denote a particular point in the phase space as Γ, and suppose that we 
can write the instantaneous value of some property A as a function of Γ, A(Γ). The 
experimentally observable value of A, Aobs is given by the ensemble average of A(Γ). 
Here, an ensemble is regarded as a collection of points Γ in the phase space. Given a 
particular ensemble, the points are distributed according to a specific probability 
distribution p(Γ). The ensemble average (or thermodynamic average) is therefore written 
as 
 
         (3.35) 
where  d! = dr1…drN ,d p1…d pN . The probability distribution (i.e. the specific 
ensemble to consider) depends on the macroscopic parameters (like the number of 
particles N, the temperature T or the pressure P) that define the experimental conditions. 
In the case where N, V and T are kept constant (canonical ensemble), the corresponding 
probability distribution is given by the Boltzmann distribution function 
      
(3.36) 
where 
 
           (3.37) 
is the canonical partition function, kB is the Boltzmann constant and H(Γ) is the value in Γ 
of the classical Hamiltonian of the system which can be written as  
 
H (!) = H ri{ }, pi{ }( ) = pi
2
2mii=1
N
" +U({ri})             (3.38) 
Aobs = A ens = A(!)p(!)d!"
pNVT =
exp !H (") / kBT[ ]
Z
Z = d!pNVT (!) = d! exp "H (!) / kBT[ ]##
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ri, pi and mi are, as usual, the position, momentum and mass of i-th atom, respectively. In 
order to calculate analytically the ensemble average, it is therefore necessary to calculate 
the partition function (Eq. (3.37)), which is an extremely difficult task. 
Molecular dynamics offers an alternative strategy to calculate the ensemble average. In 
this approach, the motion of the single point Γ through the phase space is followed as a 
function of time. The time evolution of a single point Γ through the phase space is 
obtained by integrating the equation of motion, starting from an initial point Γ(0). The 
integration yields a trajectory that is a set of points Γ(t) describing the state of the system 
at any successive time t. The “dynamical average” of A can be calculated by averaging 
over those points that have been visited 
      (3.39) 
The two averages (3.35) and (3.39) are connected by the “ergodic hypothesis”. The 
ergodic hypothesis states that if the system is at equilibrium and if it is allowed to evolve 
infinitely long in time, then it will pass through all its possible states. A system that obeys 
the condition above is said to be ergodic, and under these conditions the dynamical 
average is equal to the ensemble average for an infinitely long trajectory 
      (3.40) 
The fact that all the “real” molecular systems are assumed to be ergodic is the theoretical 
justification for employing MD simulations as a tool to calculate ensemble averages of 
molecular systems. Therefore, the application of MD simulations to calculate 
thermodynamic averages assumes that the system under investigation is ergodic and that 
the finite simulation run is sufficiently long to be a “good” approximation of the infinite 
trajectory in the statistical sense. In practice, the quality of sampling and the accuracy of 
the interatomic potentials used in simulations are always limited. In fact the quality of 
sampling may be very poor, especially for processes of time scale larger than typical MD 
simulations, and caution should be exerted when drawing conclusions from such 
computer experiments. 
The most commonly employed statistical ensemble are: 
• The microcanonical ensemble, in which the number of particles, the volume and 
the total energy are conserved. The microcanonical ensemble (NVE) may be 
considered the natural ensemble for molecular dynamics simulations. In this 
ensemble only the different states corresponding to a specific energy E have non-
zero probability of occurring. If no time dependent external forces are 
considered, the system's Hamiltonian is constant, implying that the system's 
dynamics evolves on a constant energy surface. In a computer simulation this 
theoretical condition is generally violated, due to limited accuracy in integrating 
the equations of motion and due to round off errors resulting from a limited 
precision of number representation. Tiny perturbations of the initial positions of a 
A ! =
1
!
A "(t)[ ]dt
0
!
#
lim
!"#
A($) ! = A($) $
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trajectory are doubled about every picosecond. This would mean, even for double 
precision arithmetic, that after about 50 ps round off errors would be dominant. 
This is, however, often not a too serious restriction, since most time correlation 
functions drop to zero on a much shorter time scale. Only for the case where long 
time correlations are expected one does have to be very careful in generating 
trajectories. 
• However, the microcanonical ensemble does not correspond to the ensemble in 
typical experimental conditions. A more meaningful description of the physical 
system is achieved by simulating the system in the canonical ensembles. This is 
the simplest extension to the microcanonical ensemble where the system is 
simulated at varying energy but with temperature, number of particles and 
volume that are kept constant (NVT). The temperature T is, in contrast to N and V, 
an intensive parameter. The extensive counterpart would be the kinetic energy of 
the system. In the canonical ensemble the temperature T is constant whereas the 
energy can be exchanged with the surroundings (thermal bath) and the 
distribution of states is given by the Boltzmann function. In these simulations, 
thermostat algorithm is required to control the temperature of the system during 
the MD run.  
• The isothermal-isobaric ensemble maintains constant temperature T and constant 
pressure P beyond the number of particles N. This ensemble plays an important 
role in chemistry as chemical reactions are usually carried out under constant 
temperature and pressure conditions. A barostat algorithm is required to control 
the pressure of the system during the MD run.  
In MD simulations it is possible to realize the different types of thermodynamic 
ensembles in several conceptual different ways.. If one knows how to calculate a 
thermodynamic quantity, e.g. the temperature or pressure, it is often possible to modify 
the integration algorithm in order that the corresponding evolution keep constant the 
value of this property. However, it is not always clear whether this algorithm describes 
the properties of a given thermodynamic ensemble and this has always to be kept in mind 
and possibly verified. One can distinguish four different types of control mechanisms: 
• Differential control: the thermodynamic quantity is fixed to the chosen value and 
no fluctuations around an average value occur. 
• Proportional control: the variables, coupled to the thermodynamic property f, are 
corrected in each interaction step through a coupling constant towards the chosen 
reference value of f. The coupling constant determines the strength of the 
fluctuations around the mean value of f. 
• Integral control: the system's Hamiltonian is extended and variables are 
introduced which represent the effect of an external system that fixes the state to 
the desired ensemble. The time evolution of these variables is determined by the 
equations of motion derived from the extended Hamiltonian. 
• Stochastic control: the values of the variables coupled to the thermodynamic 
property f are propagated according to modified equations of motion, where 
certain degrees of freedom are additionally modified stochastically in order to 
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give the desired mean value of f. 
3.1.4.2 Temperature control 
In order to control the temperature in an MD simulation several modifications of the 
original MD algorithm have been proposed. These methods mimic the effect of a large 
reservoir coupled to the system and they are therefore generally called thermostat 
algorithms. The temperature in an MD simulation is obtained through the equipartition 
theorem using the instantaneous value of the total kinetic energy: 
      (3.41) 
where D is the number of degrees of freedom of the system. Therefore, the thermostat 
algorithms act on the velocities of the particles. 
Various types of temperature control algorithms are implemented nowadays on the MD 
software packages, such as the ones based on a proportional method (e.g. Berendsen 
thermostat [243]), the integral type ones (e.g. Nosé-Hoover thermostat [244] Evans et al., 
1985) and the ones that used a stochastic approach (e.g. Langevin thermostat [245]). In 
the work of this thesis we employed the Langevin thermostat in the first project and the 
Nosé-Hoover thermostat in the second ones.   
Langevin thermostat 
In this thermostat the Langevin equations of motion replace the Newton's ones. 
When consider the motion of large particles through a continuum of smaller particles, it 
can be described through the Langevin equation 
 !!xi = !" # $ !xi +%&i      (3.42)  
or  
 
dqi
dt =
pi
mi
, d pidt = !
"#(q)
"qi
! $ pi +%&i
    
(3.43)  
where is the force acting on atom i due to the interaction potential, γ is a friction 
coefficient and the term  ξi  represents a random force with dispersion σ related with the 
friction coefficient. The random force is randomly determined from a Gaussian 
distribution to add kinetic energy to the particle, and its variance is the function of set 
temperature and time step. Therefore, the random force is balanced with the frictional 
force  ! !xi  and maintains the system temperature at the set value. The smaller particles 
create a damping force to the momenta, −γpi, as the large particles push the smaller ones 
out of the way. The smaller (thermal) particles also move with kinetic energy and give 
random kicks to the large particles. σ and γ are connected by a fluctuation-dissipation 
relation: 
T = 1D miv i
2
i=1
N
!
!!
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      (3.44) 
in order to recover the canonical ensemble distribution[246]. Langevin equation can be 
used for molecular dynamics equations by assuming that the atoms being simulated are 
embedded in a sea of much smaller fictional particles. In many instances of solute-solvent 
systems, the behavior of the solute is desired, and the behavior of the solvent is non-
interesting. In these cases, the description of the solvent that influences the dynamics of 
the solute via random collisions and a frictional drag force is sufficiently good. 
At each time step ∆t the Langevin thermostat changes the equation of motion so that the 
change in momenta become: 
 
!pi =
"#(q)
"qi
$ % pi + & p
'
()
*
+,
!t
        
(3.45) 
where γpi is the damping force and δp is a Gaussian distributed random number with 
probability 
            
(3.46) 
and standard deviation σ2 = 2γmikT. The damping factor and the random force combine to 
give the correct canonical ensemble. This way, the random force balances the frictional 
force and maintains the system temperature at the set value.  
Nose-Hoover thermostat  
The approach of Nose [244,247] and reformulated by Hoover [248] is based on the idea 
to consider the heat bath as an integral part of the system by addition of an artificial 
variable  !s  associated with a ”mass” Q > 0 as well as a velocity  !"s . The magnitude of Q 
determines the coupling between the reservoir and the real system and so it influences the 
temperature fluctuations. The artificial variable  !s plays the role of a time-scaling 
parameter, i.e. the timescale in the extended system is stretched by the factor  !s  
 d!t = !sdt                                                   (3.47) 
The atomic coordinates are identical in both systems. This leads to 
 
!r = r !"r = !s!1 "r
!s = s !"s = !s!1 "s                                           
(3.48) 
The extended Lagrangian of the system is chosen to be: 
 
L = mi2i!
!s2 !"r 2 "U( !r) + 12Q!
"s2 " gkBT0 ln !s                          (3.49) 
! 2 = 2" mikT
!(" p) = 12#$ e
!
" p 2
2$ 2
"
#
$
%
&
'
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The first two terms of the Lagrangian represent the kinetic energy and the potential 
energy (with opposite sign) of the real system. The additional terms are the kinetic energy 
of  !s  and its potential (with opposite sign), which is chosen to ensure that the algorithm 
produces a canonical ensemble. Moreover, g = Ndf in real-time sampling (Nose-Hoover 
formalism) and g = Ndf + 1 for virtual-time sampling (Nose-formalism). 
The Lagrangian leads to the new modified equations of motion: 
                                                            
!""ri =
!Fi
mi !s2
!
2 !"s !"ri
!s                                               
(3.50) 
 
!""s = 1Q!s mi !s
2 !"ri2 ! gkBT0
i
"#$%
&
'(                                 
(3.51) 
These equations sample a microcanonical ensemble in the extended system  ( !r, !p, !t ) . 
However, the energy of the real system is not constant. Accompanying the fluctuations of 
 !s , heat transfers occur between the system and a heat bath, which regulate the system 
temperature. It can be shown, that such equations of motion sample a canonical ensemble 
in the real system[246].
 
The Nose equations of motion are smooth, deterministic and time-reversible. However, 
because the time-evolution of the variable  !s is described by a second-order equation, heat 
may flow in and out of the system in an oscillatory fashion, leading to nearly periodic 
temperature fluctuations. 
The stretched timescale of the Nose equations is not very intuitive and the sampling of a 
trajectory at uneven time intervals is rather impractical for the investigation of dynamical 
properties of a system. The Nose equations of motion can be reformulated in terms of real 
system variables. The transformation, devised by Hoover in 1985, is achieved by 
introducing 
 
! =
!s
s         (3.52) 
in the Lagrangian equations of motion, which can be then written as 
 
!!ri =
Fi
mi
! " ri
!" =
!kBNdf
Q T (t)
g
Ndf
T0
T (t) !1
#
$%
&
'(
   (3.53) 
In both algorithms, some care must be taken in the choice of the fictitious mass Q and the 
extended system energy Ee. On the one hand, too large values of Q (loose coupling) may 
cause a poor temperature control (Nose-Hoover thermostat with Q → ∞ become an MD 
which generates a microcanonical ensemble). Although any finite (positive) mass is 
sufficient to guarantee in principle the generation of a canonical ensemble, if Q is too 
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large, the canonical distribution will only be obtained after very long simulation times. 
On the other hand, too small values (tight coupling) may cause high-frequency 
temperature oscillations.  
As a more intuitive choice for the coupling strength, the Nose equations of motion can be 
expressed as 
 
!! = " 1
# NH
T (t) gNdf
T0
T (t) "1
$
%&
'
()
    (3.54) 
with the effective relaxation time 
! NH
2 =
Q
Ndf kBT0
     (3.55) 
The relaxation time can be estimated when calculating the frequency of the oscillations 
for small deviations  ! !s from the average < !s >. 
3.1.4.3 Pressure control 
In order to control the pressure in an MD simulation cell, it is necessary to allow for 
volume variations. A simple picture for a constant pressure system is a box where walls 
are coupled to a piston that controls the pressure. In contrast to the case where the 
temperature is controlled, no coupling to the dynamics of the particles (time scales) is 
performed but the length scales of the system are modified. As for constant temperature 
methods, differential, proportional, integral and stochastic methods have been devised to 
achieve a constant pressure condition in MD simulations. In the first work of this thesis 
we employed the Nosé-Hoover/Langevin barostat [249], as implemented in the NAMD 
code, that correctly samples in an NPT ensemble if combined with the Langevin 
thermostat described above. In the second project is been employed the Andersen 
Parrinello-Rahamn barostat [250] as implemented in GROMACS code [251]. 
Nosé-Hoover/Langevin barostat 
This barostat is a combination of the Nosé-Hoover constant pressure method [252] where 
an extra degree of freedom corresponding to a piston is added into the equations of 
motion, and the piston fluctuation control implemented by using a Langevin dynamics as 
in [249].  
The complete set of equations of motion used in NAMD when both the barostat and the 
thermostat are enabled is: 
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(3.56)  
where γ is the parameter and ξ  the random noise of the Langevin thermostat, W is the 
mass of the piston, the oscillation period τ is the barostat time constant, and ξ ε is the 
random noise on the piston. Therefore, the piston represents an additional degree of 
freedom, which undergoes a Langevin-like dynamics, in analogy with the motion of each 
particle. 
Andersen Parrinello-Rahamn barostat 
Parrinello and Rahman generalized the Andersen’s idea and introduced the volume as 
additional dynamical variables for the anisotropic pressure coupling [250]. 
Let h be the matrix that has simulation box vectors {a,b,c}  as column and denote the 
volume V = det(h) = a · b × c of the box. The equations of motion for the system with this 
barostat are: 
 
d 2ri
dt 2 =
Fi
mi
! M dridt     
 (3.57) 
 
M = h!1 h dh 'dt +
dh
dt h'
"
#$
%
&'
h '!1                 (3.58) 
In this scheme, h represents a new degree of freedom that obeys to the matrix equation of 
motion: 
 
dh2
dt 2 = VW
!1h '!1(P ! Pref )
   
 (3.59) 
where W is a matrix parameter that determines the strength of the coupling and how the 
box can be deformed. The matrices P and Pref are the current and reference pressure 
tensors, respectively. 
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V = 3V '!
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3.2 REPLICA EXCHANGE SOLUTE TEMPERING DYNAMICS 
	  
3.2.1 Introduction 
Sampling the conformational space of complex biophysical systems, such as proteins 
remains a significant challenge. The inefficiency in sampling is a result of the ruggedness 
of the systems’ free energy landscape [253,254], i.e the free energy of the system as a 
function of all structural degrees of freedom. The global shape of the free energy 
landscape of a protein system is supposed to be funnel-like, with the native state 
populating the global energy minimum [255]. Looking in more detail, the complex high-
dimensional free energy landscape is characterized by a multitude of almost iso-energetic 
minima, separated from each other by energy barriers of various heights. Each of these 
minima corresponds to one particular conformational substate, with neighboring minima 
corresponding to similar conformations. Within this picture, structural transitions are 
barrier crossings, with the transition rate depending on the height of the barrier. In MD 
simulations at room temperature, only those barriers that are smaller than or comparable 
to the thermal energy kBT are easily overcome. However, the corresponding structural 
changes are almost always small, e.g. side chain rearrangements. In these simulations the 
system spends most of the time in locally stable states (kinetic trapping). Much more 
interesting, due to their connection to biological functions, is the exploration of different 
conformational states and the mechanism of global conformational transitions, which 
require the system to overcome large energy barriers. Since MD simulations are mostly 
restricted to the nanosecond timescale, functionally relevant conformational changes are 
therefore rarely observed. A plethora of enhanced sampling methods have been 
developed to tackle this multi-minima problem, see e.g. [256-258] and references therein. 
For example, one strategy is to perform a simulation based on non-Boltzmann probability 
weight factors so that to realize a random walk in the energy space. Such random walks 
allow the system to cross any energy barrier and to sample a much wider phase space 
region than conventional methods do. Monitoring the energy in a single simulation run, 
one can obtain not only the global minimum-energy state but also any thermodynamic 
quantities as a function of temperature for a wide temperature range. One such well-
known method is the multicanonical algorithm. While a simulation in a multicanonical 
ensemble performs a free 1-dimensional random walk in energy space, a simulated 
tempering simulation performs a free random walk in the temperature space. The last 
random walk, in turn, induces a random walk in energy space and allows the simulation 
to escape from local energy minimum states. These methods which perform random 
walks in energy space due to non-Boltzmann weight factors are nowadays grouped under 
the generic name generalized-ensemble algorithms (reviews in [259,260]).  
The generalized-ensemble approach is powerful but the probability weight factors are 
usually not known a priori and they have to be determined usually by iterations of short 
trial simulations. This process can be non-trivial and very tedious. The replica-exchange 
molecular dynamics (REMD) method [156] is an alternative technique where the weight 
factors are essentially known and there is no complications in their determination. In the 
second project of this thesis, one of the variants of the REMD, the so-called replica 
exchange with solute scaling or REST2, has been employed to explore the 
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conformational space of the N-term acetylated alpha synuclein. The method was 
implemented in GROMACS 4.5.5 program [251] and constant temperature and pressure 
conditions have been achieved by coupling the system with a Nose-Hoover thermostat 
[247,248] and an Andersen-Parrinello-Rahman barostat [250]. 
 
3.2.2 Replica Exchange method  
The REMD scheme is a powerful computational technique to enhance conformational 
sampling that has been successfully used to investigate peptide folding in the gas phase 
[156], as well as in implicit [261], and explicit [262] solvent models. In this approach 
several copies of the same system are simultaneously simulated, each replica at a 
different temperature. Each replica therefore can explore a different portion of the 
conformational space: the higher temperature replicas are able to move between different 
regions of the potential energy surface without dwelling in any of them, while the lowest 
temperature replicas can be trapped in local minima but at the same time are able to 
accurately explore the regions of the potential energy surface by sampling them with the 
correct Boltzmann probability. At given intervals of time, the REMD simulation 
algorithm gives any replica the chance to swap its coordinates to adjacent replicas, 
allowing low temperature replicas to explore conformations visited by higher temperature 
replicas and vice versa. A swap between two adjacent replicas is probable if there is an 
overlap between the potential energy distributions of the two replicas. 
This method results time-consuming in its applications for large systems, since it requires 
a high number of replicas to work. To overcome this problem, Liu et. al [263]  proposed 
the so-called Replica exchange with Solute Tempering (REST) variant. 
In the REST method the system (e.g. a protein solvated in water) is split into two parts: 
the solute (e.g. a protein) and the solvent (e.g. water). In each replica the potential energy 
is properly rescaled such that the protein molecule has a different “effective temperature” 
as in the spirit of the REMD method while the solvent effective temperature is the same 
in all the replicas. Note that while the number of replicas required to get efficient 
sampling in REMD scales as the squared root of the degrees of freedom of the whole 
system √Ndf, limiting the applicability of REMD for very large systems, the number of the 
replicas required in REST is reduced and scales as √Ns, where Ns is the number of 
degrees of freedom of the solute only. Therefore, compared with the conventional REMD 
method, the REST improves the scaling with system size by reducing significantly the 
number of replicas [263]. In this project we employed the most recent implementation of 
this scheme, named the REST2 approach, where some computational time is also saved at 
each exchange [47] since this algorithm does not require rescaling the velocities during 
the swap step, as it is necessary in the REMD algorithm. 
3.2.2.1 Theory background of REMD  
Consider a simulation system of N atoms of mass mk (k = 1, . . . , N) with their coordinate 
and velocity vectors denoted by x = (x1, . . . , xN) ∈ R3N, xi ∈ R3 and v =(v1, . . . , vN) ∈ R3N, 
vi ∈ R3, respectively. The Hamiltonian H(x, v) is as usual given by the sum of the 
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potential energy E(x) and the kinetic energy : 
                  (3.60) 
In the canonical ensemble at temperature T, the probability for the system to be in the 
state s = (x, v) is given by the Boltzmann factor W(s) = exp {−βH(s)}, with the inverse 
temperature β−1 = kBT and kB the Boltzmann constant. Via the equipartition theorem, the 
average kinetic energy is linked to the number of degrees of freedom Ndf of the system, 
.      (3.61) 
Usually Ndf ≪ 3N since constraint algorithms [239,264] considerably restrict the number 
of degrees of freedom. As soon as flexible bonds are simulated, Ndf = 3N and the standard 
textbook expression for a free N-particle system is recovered. 
In REMD, a generalized ensemble is constructed, which consists of M+1 non-interacting 
copies (or replicas) of the original system in the canonical ensemble with temperatures 
{T0, T1, . . . , TM} and Tm ≤ Tm+1  (m = 0, . . . ,M). Equal temperatures for two or more 
replicas are possible, but seldomly used. A state of this generalized ensemble is 
characterized by , where the configuration  represents 
the coordinates  and velocities  of all the atoms of the ith replica at temperature 
Tm. Because the replicas are non-interacting, the statistical weight of a state S of this 
generalized ensemble is given by the product of the Boltzmann factors for each replica, 
      (3.62) 
We now consider an exchange between a pair of replicas i and j, 
    (3.63) 
In more detail, (3.63) reads 
     (3.64) 
which corresponds to an exchange of configurations of the two replicas. It is interesting 
to note that this configuration exchange is equivalent to exchanging a pair of 
temperatures Tm and Tn, 
     (3.65) 
K(v) = mkvk
2
2k=1
N
!
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(
S = …, sm[i],…, sn[ j ],…{ }! S ' = …, sm[ j ],…, sn[i],…{ }
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Unlike the original implementation of replica exchange approach in Monte-Carlo 
simulations [175] [265] [266], applying the replica exchange scheme to MD requires a 
rescaling of velocities, indicated by the primes in Eq. (3.64) and Eq. (3.65). Velocity 
rescaling is done in such a way, that the equipartition theorem (3.61) holds for each 
replica at all times. To this end, we look at the situation immediately after a temperature 
exchange S → S′. Starting with replica , the equipartition theorem reads 
. Upon exchange, replica has the rescaled velocities of 
replica , for which . Combining both expression yields 
. Since K(v)~v2 , we the simplest way to satisfy the 
condition above is to fix the primed velocities to the values: 
             and   .   (3.66) 
This way all the atoms of the replicas are rescaled uniformly. 
For the exchange process to converge towards the equilibrium distribution (3.62), it is 
sufficient to impose the detailed-balance condition on the transition probabilities 
(exchange/acceptance probability) P(S → S′): 
W(S)P(S → S′)= W(S′)P(S’ → S) .               (3.67) 
that is: 
          (3.68) 
In the last step we used the fact that the potential energy of the system immediately after 
exchange solely depends on the respective conformation of the system and not on the 
temperature; thus,  and . Detailed-balance can be satisfied by the 
usual Metropolis Monte-Carlo criterion: 
 
 .     (3.69) 
 
For simulations performed in the NPT-ensemble, Eq. (3.69) is modified by a pressure 
sm[i] = (xm[i],vm[i] )
2 K(vm[i] )) Tm = Ndf kBTm sn
[i] '
sm[i] 2 K(vn[i] ')) Tn = Ndf kBTn
K(vn[i] ')) Tn =
Tn
Tm
K(vm[i] )) Tm
vn[i] ' =
Tn
Tm
vm[i] vm[ j ] ' =
Tm
Tn
vn[ j ]
P(S! S ')
P(S '! S) =
exp{"#mH (sm[ j ] ')}exp{"#nH (sn[i ] ')}
exp{"#mH (sm[i ] )}exp{"#nH (sn[ j ] )}
= exp{"#m[H (sm[ j ] ')" H (sm[i ] )]" #n[H (sn[i ] ')" H (sn[ j ] )]}
= exp{#m[E(xm[i ] )" E(xm[ j ] )]" #n[E(xn[i ] )" E(xn[ j ] )]}
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correction term [267]. Putting everything together, a simulation using the REMD 
algorithm is realized by alternately performing the following two steps:  
• simultaneous and independent simulation of each replica for a certain number of 
MD steps  
• exchange of two replicas according to the Metropolis criterion (3.69) between 
any two adjacent (in temperature) replicas. 
In fact, only neighboring replicas are exchanged since the acceptance probability (3.69) 
exponentially decreases with the temperature and potential energy difference ΔβΔE. 
Within the generalized ensemble S a random walk in temperature space is performed, 
which corresponds into a random walk in potential energy space for a single replica. This 
facilitates an efficient and statistically correct conformational sampling of the rugged free 
energy landscape of the system. 
 
3.2.3 Replica Exchange with Solute Scaling method (REST2) 
The Replica Exchange with Solute Scaling (REST2) method [47] is a variant of the 
Replica Exchange with Solute Tempering (REST) approach [263]. In REST only the 
protein (i.e. the solute) is simulated at different effective temperatures by applying an 
appropriate potential energy function to each replica.  
This methodology is particularly suitable for systems as large as those considered here 
(ca. 99,000 atoms).  
In REST2, the total interaction energy of the system is decomposed into three 
components: the protein intra-molecular energy, Epp; the interaction energy between the 
protein and water, Epw; and the self-interaction energy between water molecules, Eww.  
E = Epp + Epw + Eww      (3.70) 
All of the replicas are run at the same temperature T0, but the potential energy for the 
highest temperature replica H is given by, 
EHREST 2 (S) =
!H
!0
Epp (S) +
!H
!0
Epw (S) + Eww (S)             (3.71) 
where β H and β 0 are the inverse of the highest and lowest effective replica protein 
temperature, respectively. The scaling factor for Epw independently obtained by Moors et. 
al. and Terakawa et. al. [174] include only part of the protein in the “hot region”, keeping 
the rest of it “cold”. 
The energy potentials for the intermediate replicas m are defined as the linear 
combination of the two-end potentials defined above, 
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 (3.72) 
where λ m is related to the effective inverse temperature βm of replica m through the 
formula 
!m =
"m # "0
"H # "0
         (3.73) 
The acceptance ratio for the exchange between two replicas m and n depends on the 
following energy difference 
   (3.74) 
The number of replicas and values of effective temperature can be estimated using the 
approach of ref. [268], in which only the number of protein’s atoms is taken into account. 
3.2.3.1 Implementation of REST2 
The method has been implemented through Gromacs 4.5.5 code by exploiting the λ-
dynamics feature [174]. λ-dynamics algorithm allows one to run simulations in different 
conditions spanning between two different states of the same system (called A and B, 
corresponding to λ = 0 and 1, respectively). In the considered case, the state A is the 
whole system, which has been equilibrated at T = TL. To define the state B, a portion of 
the force field parameters of the state A (i.e. those belonging to the solute, given by the 
protein) are scaled according to the equations (3.75) and (3.76) reported below, while the 
solvent parameters are left unchanged: 
 
(3.75) 
 
 
(3.76) 
 
 
 
where TH is the effective temperature of the highest temperature replica, qi is the partial 
charge of the ith atom, εi is the depth of the van der Waals well of the ith atom, and ka, kb, 
and kt are the bond, angle, and torsional force constants for the bonds defined for the ith, 
jth, lth, and mth atoms, respectively. Replicas at different intermediate effective 
temperature Tλ spanning from TL and TH 
                                     (3.77) 
can then be specified by simply providing the value of λ 
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                                                        (3.78) 
 
and all the corresponding force field parameters listed in equation (3.76) (for the highest 
temperature replica) will be calculated accordingly. 
 
 
 
  
 
! =
TL "T!
T! (# "1)
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CHAPTER 4 
 
 
 
 
 
 
4. CONFORMATIONAL INDICES 
	  
4.1 INTRODUCTION 
 
Protein plasticity plays a key role for molecular recognition in a variety of cellular 
processes such as signaling, metabolism, protein aggregation, and gene expression) [269-
273]. Plasticity is often affected by the presence of an interacting partner (chemicals 
and/or macromolecules) [274,275]. Therefore, strategies able to quantify the residues’ 
plasticity in the presence and in the absence of an interacting partner may be crucial for 
understanding protein dynamics and function {Clayton, 1998 #57;Dunker, 2008 #76}.  
Our group recently proposed an analysis tool able to detect, residue-by-residue, high 
plasticity sites in folded proteins, backbone transitions between two conformations of the 
Ramachandran plot and the so called “hinge” points for conformational changes from 
MD simulations [31]. During my thesis I have adapted such tool to IDPs, for which 
obviously, plasticity is absolutely crucial. The chapter is organized as follow: first, I 
provide an overview of the tool’s methods and the algorithm on which it is based. Next, I 
show how I have adapted the tool on IDPs. 
 
4.2 CHARACTERIZATION OF PROTEIN PLASTICITY: THEORETICAL BASIS OF 
CONFORMATIONAL INDICES. 
 
Local fluctuations and conformational transitions in protein can be studied by means of 
indices defined in terms of the values of the Ramachandran angles ψj and φj (not to be 
confused with the torsion angle between Cα-C-N-Cα in a peptide bond) collected along a 
MD trajectory for each residue of a protein. Being torsion angle, they can be considered 
cyclic variables [276] and hence treated with circular statistic [277]. In particular, the 
circular mean and circular spread replace, respectively, the average and the standard 
deviation calculated for non-angular variables [278].  
Consider N values ωj of an angular variable ω. In direction statistics, these values are 
associated with N unit vectors of the type !!!!. The circular spread of the angle ω (CSω) 
(See Appendix A1) may be calculated from the resultant of such unit vectors 
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     (4.1) 
where ω = Φ + ψ 9 and  
    (4.2) 
are the lengths of the so called “sample moments” of the first (k=1) and second (k=2) 
order. NRkω represent the resultants of the N unit vectors !!"!!. Therefore, CSω ranges 
between 0 (no dispersion, R1ω= R2ω =1, the vectors !!"!!   are aligned along a unique 
direction) and infinity (maximum dispersion, R1ω= R2ω =0, the vectors !!"!!    are 
randomly distributed).  
 
4.2.1 Protein local flexibility 
The circular spread has been used to analyse the plasticity of the globular domain's prion 
protein backbone [279]. However, CSω alone cannot provide information on the 
conformation of the backbone, characterized by the two Ramachandran angles. In 
addition, CSω range from 0 to infinity. This does not allow a comparison of circular 
spreads across different residues in the same protein, or the same residue across different 
proteins.  
Therefore, a new quantity (Protein Angular Dispersion of the angle ω, PADω) has been 
introduced that overcomes these problems and is well suited to quantify the plasticity of 
protein backbone residues. PADω differs from CSω in two aspects: (1) it is function of ω 
= Φ + ψ, hence dependent on both Ramachandran angles; (2) PADω is formulated so as 
to range between 0° and 180°, allowing for quantitative comparisons among residues and 
among proteins (notice that ω can instead range between 0° and 360°).  
PADω reads: 
         (4.3) 
PADω is 0° when the Φ and ψ dihedral angles of the residue do not change across a set of 
protein structures. It is 180° when the Φ and ψ dihedral angles assume random values. It 
can be applied to a set of structures determined by NMR or simulated by MD. 
 
PADω quantifies the protein backbone plasticity but does not allow discrimination 
between fluctuations and transitions (from one region of the Ramachandran plot to 
another in MD simulations) when they occur with the same amplitude. 
Graphically, from Figure 4.1 the resultant of the N unit vectors NR1ω, and hence the 
values of CSω and PADω, obtained from the same set of unit vectors !!"!! but distributed 
in two different ways are the same: in the first set, the vectors fluctuate around a given 
direction (Figure 4.1a), i.e., identified as a fluctuation, and in the other one they fluctuate 
around two separate directions (Figure 4.1b), i.e., recognizing a transition (we can say 
that a transition occurs when two consecutive subsets of unit vectors !!"!!   show different 
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
9 Notice that ω, as defined here, does not refer to the torsion angle Cα−C−N−Cα in a peptide bond 
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common directions and the change in direction is greater than the intrinsic fluctuations 
within each subset). 
Therefore, we have introduced new quantities able to make such a distinction.  
 
4.2.2 Discriminating fluctuations from transitions for structured proteins: the 
phase Angular Index PAIω and the Cumulative Protein Angular Dispersion index 
(PADcum)ω  
In MD simulations, the ωj values can be ordered as a time series. By exploiting this fact, 
it is possible to identify a mathematical condition involving two quantities (the 
cumulative protein angular dispersion (PADcum)ω and the Phase Angular Index, PAIω) that 
allow distinguishing between long transition (i.e., contributing more than 30% of the 
simulation time), short transition (i.e. contributing less than 30% of the simulation time), 
and fluctuations.  
(PADcum)ω discriminates fluctuations from transitions with respect to their amplitude 
while PAIω discriminates with respect to their frequency. Therefore, the two quantities 
per se are not sufficient for a complete discernment of transitions among fluctuations: 
their simultaneous evaluation is required.  
 
4.2.2.1 (PADcum)ω 
(PADcum)ω introduces the memory of the time series: 
 
,       (4.4) 
where ,  for k=1,2;  (see Appendix A2) is the angle 
formed by the cumulative vector 
 
, which is the sum of the vectors occurring 
in the first j frames and ωp=ψp+φp.  
(PADcum)ω  is an angular property and varies in the range [0°, 180°]. It increases with the 
deviations of the  vectors from the direction of the resultant vector. As an 
example, let us take a set of six vectors ( ; p=1,2,...,6) associated with fluctuations 
(see Fig. 4.1a) or conformational transitions (see Fig. 4.1b), depending on the 
vectors’ orientations. The (PADcum)ω values in the two cases differ because the 
corresponding vectors  depend on the orientation of the vectors.  
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Figure 4.1 Ramachandran angle representations. Representations in the complex plane of N = 6 unit 
vectors  (black) and   (red), where the angular values ω p fluctuate around a given direction (a) 
and undergo a transition between two perpendicular directions (b). The  values are ordered in a 
different way in panels a) and b): they give different values of (PADcum)ω, lower for panel a) and higher for 
panel b): they give the same value of . The  vectors are different in a) and b): they give different 
values of (PADcum)ω, lower for a) and higher for b). 
  
4.2.2.2 PAIω 
PAIω index is a function of CSω and the so-called Angular Transition Index (ATIω) 
developed by adapting the studies of Hurst to time series of angular data (see Appendix 
A3). ATIω is able to recognize the presence of transitions, distinguishing them from 
random, even large, fluctuations. 
 
     (4.5) 
PAIω varies in the range [0°, 90°]. 
 
We clarify how these indices work with a numerical example. 
 
4.2.3 Numerical model for structured proteins 
As a toy model for structured proteins, the human ubiquitin in aqueous solution was 
simulated. The Ramachandran ψ angle of residue ASN60 was monitored between 9 and 
10 ns of such a simulation. In the case of no transition, the ψi values fluctuate around an 
average value during the simulated time, (1 ns) (Fig. 4.2a). Note that the amplitude of the 
intrinsic fluctuations of a protein residues on a given direction is A=30°. Introducing 
hypothetical transitions with period (τ) of 240 ps and an amplitude (A) of 90°, the ψi 
instead experiences changes larger than its baseline (Fig. 4.2b). 
On the basis of the correlation plots of our numerical example, PAIω does not depend 
significantly on A but does distinguish fluctuations from short and long transitions based 
on the value of τ (Figure 4.3). Values of PAIω < 30° are associated with fluctuations. 
Those comprised between 30° and 60° are associated with long transitions. Finally, large 
values (60° < PAIω < 90°) occur for short transitions. 
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It can be noted that in this case a clear tagging may be achieved by the combined use of 
PAIω and (PADcum)ω.  
 
 
	  
Figure 4.2 Numerical example for structured protein. Ramachandran angle ψ of residue MET1 of ASN60 of 
human ubiquitin. Values of the Ramachandran angle ψ of residue ASN60 of human ubiquitin, plotted as a 
function of simulated time in a 1ns of MD simulation (a). In (b) hypothetical transitions of amplitude A and 
period τ are introduced 
 
	  
Figure 4.3 Correlation plots of (PADcum)ω (a) and PAI (b) against τ and a in numerical example for 
structured protein. Similar curves are obtained for amplitudes in the range [180°, 360°]. Colored areas 
indicate the expected tagging: fluctuations for τ<200ps (very frequent transitions) or τ>950ps (no 
transitions) or A≤30° (transition amplitude comparable with that of the intrinsic fluctuations of the baseline) 
(blue); long transitions for 200<τ<700 ps and A>30° (red); short transitions for 700<τ<950 ps and A>30° 
(green). PAI and (PADcum)ω provide the best discrimination with respect to parameters τ and A respectively. 
A
τ
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b)
ττ
b)a)
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4.3 APPLICATION OF CONFORMATIONAL INDICES TO IDPS  
 
4.3.1. Flexibility 
In this thesis we faced the problem of estimating the effect of a small molecule, dopamine 
(DOP) on the flexibility and dynamic properties of an IDP, α-synuclein (AS).  
PADω quantity has been applied on AS and it can successfully detect local residues 
flexibility by avoiding problems associated with Cartesian coordinates, which are biased 
by the problematic alignment of extremely flexible structures, besides being affected by 
the movements of neighbouring residues [31,278].  However, unfortunately PADω index 
was not sensitive enough in detecting differences in residue-by-residue flexibility of AS 
with and without DOP. 
 
Therefore, we introduce another index. This is the so-called Transition Amplitude index 
(TAIω), which quantifies the amplitude of motion for each residue.  
When applied on AS in complex with DOP, TAIω was able to quantitative detect 
differences in the amplitude motion of the protein’s residues due to ligand binding (see 
Chapter 5). 
The Transition Amplitude Index TAIω is defined as: 
 
.       (4.6) 
 
It varies in the range [0°, 180°] and it is a function of CSω. 
 
In the next paragraph we illustrate how this index works with a numerical example by 
taking into account the 1ns-long evolution of the Ramachandran Φ angle of the residue 
MET1 of AS in aqueous solution.  
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Figure 4.4 Numerical example for IDP. Ramachandran angle Φ of residue MET1 of AS. (a) On the top, the 
values of the Ramachandran angle Φ of residue MET1 of AS, as a function of time during a 1ns-long MD 
simulation. (b) Hypothetical transitions of amplitude A = 120° and period τ = 200 ps . 
 
Φ turns out to fluctuate around an average value of 30°, with an amplitude A0=50° and a 
period τ0 = 25 ps (Fig. 4.4a). We introduced periodic transitions having a period τ and 
amplitude A (Fig 4.4b). Through a systematic variation of these two parameters (A, τ), we 
observed TAIω features. 
 
4.3.2 TAIω properties 
TAIω values are nearly constant when τ varies from 0 to the total time T of simulated time, 
and they nearly reproduce the values of the parameter A (Fig. 4.5), except in case when 
the amplitude of the periodic transitions introduced is smaller than the amplitude of the 
baseline fluctuation  (A< A0), or the transitions occur for a negligible fraction of the 
simulated time (τ << T). In these cases the TAIω value approximates the value of the 
baseline fluctuation amplitude (TAIω  ≈ A0).  Hence, we conclude that for non-negligible A 
and τ, TAIω gives an estimate of A, independently on τ value.  
 
This feature is particularly suitable for IDPs for which a high frequency of backbone 
conformational transitions (1/τ) is often unaffected by the binding of a small ligand. 
 
A
τ
a)
b)
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Figure 4.5 Correlation plots of TAIω  against τ  and A in the numerical example for IDP. Plot of TAIω  as a 
function of the parameter τ, for different values of the parameter A. 
 
4.3.2.1 Conformational transition: the tagging indices: (PADcum)ω and PAIω properties in 
IDPs 
For folded proteins, (PADcum)ω was combined with PAIω [31] for discriminating residues 
doing transitions from the ones only fluctuating.  
However, by using our previously described numerical example we have shown that PAIω 
is not able to discriminate conformational transitions from fluctuations through their 
frequency.  
Indeed PAIω assumes similar values in the both cases in which τ<50ps (fluctuations) and 
50<τ<700 ps (transitions).  
 
We believe that for IDPs is more suitable an index depending on the amplitude of 
transitions instead of their frequency. IDPs are indeed characterized by a high frequency 
of conformational transitions creating an intrinsic noise from which it is challenging to 
detect fluctuations from residues’ transitions. 
 
On the contrary, for IDPs (PADcum)ω assumes new features and it is able alone to 
discriminate cases in which transitions are dominant from those in which only 
fluctuations occur (Fig. 4.5A).  
 
Specifically, when A and τ of the introduced periodic transitions are comparable or 
smaller than the amplitude and the period of the baseline fluctuation (A ≤ A0 and τ ≤ τ0), 
the vectors’ orientations do not (or slightly) deviate from the baseline direction. 
Hence, the index (PADcum)ω assumes small values (lower than 18° in this specific case, 
see Fig. 4.6A), which is a signature of an angle ωp=ψp+φp fluctuating. (PADcum)ω has the 
same response if a single transition occurs, lasting for the majority of the total time T 
(specifically τ > 3/4 T).  In all the other cases (A > A0 and/or τ0 < τ < 3/4 T), the 
ei! j
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vectors’ orientations strongly deviate from the baseline direction, which is a signature of 
an angle ωp=ψp+φp doing transitions. Hence, the (PADcum)ω index assumes larger values 
(larger than 18° in this specific case, see Fig. 4.6B).  
 
Therefore, for our specific application case, AS and DOP, we successfully use only 
(PADcum)ω for detecting conformational transitions. 
 
Figure 4.6 Correlation plots of PAIω  (A) and (PADcum)ω  (B) against τ  and A in the numerical example for 
IDPs. Similar curves are obtained for amplitudes in the range [180°, 360°]. Colored areas indicate the 
expected tagging: fluctuations for τ < 50ps (very frequent transitions) or τ > 700ps (short or no transitions) 
or A ≤  50° (transition amplitude comparable with that of the intrinsic fluctuations of the baseline) (blue); 
transitions for 50 < τ < 700 ps and A>50° (red). PAI  does not provide a clear discrimination between 
transitions and fluctuations. 
 
4.4 (PADCUM)ω-DERIVED QUANTITY USED FOR COMPARISON WITH VARIATIONS OF 
CHEMICAL SHIFTS 
 
In this work, we consider the quantity 
 
    (4.7)  
 
where   and   are the values for the AS•DOP 
adducts and the free AS, respectively. The average is calculated over the configurations 
of the proteins and adducts. 
 
4.5 PRINCIPAL COMPONENT ANALYSIS (PCA) ON TAIω 
 
PCA is a multivariate analysis technique, a projection method to visualize complex data 
by reducing the dimensionality in a data set. The data matrix is decomposed into a 
number of principal components (PCs) that maximize the variance in the data on each 
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successive component, under the constraint of being orthogonal to the previous PCs. 
They are calculated as eigenvectors of the covariance matrix of the data, and the 
magnitude of the corresponding eigenvalues represents the variance of the data along the 
eigenvector directions [280]. The initial dimensionality of the data set, equal to the 
number of columns (N), is reduced to n, representing the number of PCs to be used for 
the analysis. The optimal value of n can be determined by considering the sum of the 
eigenvalues of the selected PCs, which represents the data variability explained by the 
chosen PCs. The spectra of eigenvalues can be projected into a new coordinate system, 
where the PCs form the axes. Plots based on this coordinate system are referred to as 
score plots, and they can be used to reveal patterns in the data. Score and loading vectors 
are two alternative representations of the data matrix: the former carries information 
about samples in the variable space, the latter about variables in the sample space. Score 
plots generated from PCA method provide visual representations of information-rich 
spectral data by means dimensionality reduction. Orthogonal lines of maximum gross 
variation are found within the data, termed “principal axes”, onto which the input data are 
transformed [281]. This operation preserves as much original gross variation as possible 
in the first few transformed dimensions and reveals separations between groups only 
when the within-group variability is sufficiently less than the between-group variability. 
The resultant two-dimensional scores plot is used to identify spectral features 
contributing to between-group variability based on separations observed between groups 
in the scores plot. The interpretation of PCA scores plots necessitates the use of 
quantitative procedures to determine the significance of these group separations. 
Hypothesis testing using a Mahalanobis distance metric and the T2 and F-distributions 
can provide a statistical means to infer cluster similarity [282], suggesting the possibility 
of returning p values for full statistical quantitation of PCA group separations.  
 
In my thesis I used PCA technique on (PADcum)ω  and TAIω values. In the first case, PCA 
was able to reveal differences between the protein conformations with and without the 
presence of DOP, in the second case it was able to distinguish between the six 
configurations. Since this second feature is more interesting regarding our application, 
only the results of PCA applied to TAIω index will be reported in the following.. For more 
details see Appendix, section B. 
 
4.5.1 Probability calculation 
Under the assumption that each group in the scores space is distributed as a multivariate 
normal random variable, the distances between groups may be calculated using the 
squared Mahalanobis distance metric [283], 
 
    (4.8) 
 
Here, ui and uj are the p-variate sample means of groups i and j, respectively, and Sp is the 
pooled p-by-p variance–covariance matrix, a weighted average of the covariance matrices 
from groups i and j. The Mahalanobis distance may then be related to a Hotelling’s T2 
statistic by the scaling [284]. 
DM2 = (uj ! ui )T Sp!1(uj ! ui )
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(4.9)  
 
where ni and nj are the number of data points in groups i and j, respectively. This T2 
statistic is an extension of the Student t statistic to hypothesis tests in multiple dimensions 
and can be related to an F distribution by a final scaling [284] : 
 
       
(4.10)  
 
Evaluation of the complement of the cumulative F-distribution function at xF yields the p 
value for accepting the null hypothesis: the points in groups i and j are in fact drawn from 
the same multivariate normal distribution. 
 
4.5.2 Confidence ellipse calculation 
When viewing PCA scores plots, it is common practice to apply hand-drawn ellipses to 
inform group membership or even to omit such ellipses entirely. This may lead to 
inconsistent or erroneous interpretation of results. Instead, the fact that the Mahalanobis 
distances of a set of p-variate points from their sample mean follow a χ2 distribution 
having p degrees of freedom [285] may be leveraged to estimate 95% confidence 
ellipsoids for scores in any number of dimensions. The sample mean u and covariance 
matrix S for each group must first be calculated from its scores space data. Then, the 
group covariance matrix is decomposed into its eigenvalues and eigenvectors, 
 
S=Q Λ Q-1        (4.11) 
 
where Q is a p-by-p matrix whose columns are the eigenvectors of S, and Λ is a diagonal 
matrix of the corresponding eigenvalues of S. For the case of two-dimensional scores 
data, the 95% confidence ellipse for the group follows, 
 
    
   (4.12)  
where is the value of the inverse χ2 cumulative distribution function at α = 0.05 and 
2 degrees of freedom, and the square root is taken element-wise over Λ.  
This method allows for the inclusion of confidence regions onto two-dimensional scores 
plots that reflect the 95% membership boundaries for each group. The approach assumes 
normally distributed data. The ellipses and ellipsoids clearly define statistically 
significant class separation and could also provide an example in which multiple groups 
actually belong to the same classification.  
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CHAPTER 5 
 
 
 
 
 
 
5. A MOLECULAR DYNAMICS SIMULATION-BASED INTERPRETATION OF 
NUCLEAR MAGNETIC RESONANCE MULTIDIMENSIONAL HETERONUCLEAR 
SPECTRA OF Α ‑SYNUCLEIN·DOPAMINE ADDUCTS 
 
Abstract. Multidimensional heteronuclear NMR spectroscopy provides valuable 
structural information on adducts between naturally unfolded proteins and their ligands. 
These are often of high pharmacological relevance. Unfortunately, the determination of 
the contributions to observed chemical shifts changes upon ligand binding is complicate.  
In this chapter is presented a tool that uses molecular dynamics (MD) trajectories to help 
interpret 2D NMR data.  We apply this tool to the naturally unfolded protein human α -
synuclein interacting with dopamine, an inhibitor of fibril formation, and with its 
oxidation products in water solution. By coupling 2D NMR experiments with MD 
simulations of the adducts in explicit water, the tool confirms that the ligands bind 
preferentially to 125YEMPS129 residues in the C-terminal and, to few residues of the so-
called NAC region, consistently with experimental data. It also suggests that the ligands 
might cause conformational rearrangements of distal residues located at the N-terminal. 
Hence, the performed analysis provides a rationale for the observed changes in chemical 
shifts in terms of direct contacts with the ligand and conformational changes of the 
protein.  
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5.1 INTRODUCTION 
 
The human α -synuclein protein (AS hereafter) is a midsize[286-288] [140 amino acids 
(Figure 4.1A)] intrinsically disordered protein (IDP) involved in Parkinson’s disease.4 
The protein forms fibrillar aggregates in the brain (Lewy bodies), characteristic of the 
disease[205] [202] [289].These fibrils may also mediate the toxicity to dopaminergic 
neurons in Parkinson’s disease pathogenesis and in cell death [34-36]. 
Dopamine and its derivatives (DOP) [290,291] in Fig. 5.1B are known to inhibit AS fibril 
formation in vitro and in vivo [132,204,290,292-296] (see Appnedix C1). Inhibition of 
fibrillation may be achieved by non-covalent10 binding of DOP to the AS C-terminal 
region specifically targeting the 125YEMPS129 region [132,292,293,295]. Recently, 2D 1H-
15N Heteronuclear Single Quantum Correlation (HSQC) spectra of AS•DOP [143] have 
shown non-covalent binding of DOP at the C-terminal of AS. This binding may play a 
role for the DOP-induced inhibition of AS fibril formation [292,293].  
 
 
 
 
 
 
 
 
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
10 Also covalent binding may affect fibril formation [141,143,204,290,297-301] 
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Figure 5.1 (A) Schematic representation of AS protein. AS consists of 140 amino acids. (i) The positively 
charged N-terminal region (amino acids 1–60, in blu) comprises the seven imperfect 11 amino acids repeats 
containing the consensus sequence KTKEGV. (ii) The non-β-amyloid component (NAC, in violet) comprises 
amino acids 61–95. (iii) The negatively charged C-terminal region (amino acids 96–140, in red) contains 
several sites of post-translational modifications. The 125YEMPS129 region is show in green. (B) Dopamine 
and its derivatives, which may be present in vivo and in vitro [290,291]. These are: Protonated Dopamine 
(DOPH), Dopamine (DOP), Dopamine-o-quinone (DQ), Dopaminochrome (DCH), 5,6-Dihydroxyindole 
(DHI), Indol-5,6-quinone (IQ). (C) AS-DOP Contacts. An MD Snapshot of DOP non-covalently bound to AS 
in the representative configuration 2 is shown as an example. Both a 3D representation and an interaction 
scheme (obtained by Ligplot program [302]) are shown.  In the 3D representation, the atoms involved in the 
binding are shown as a combinations of “lines” and “cartoon” representation, while the molecule is shown 
in “licorice”. In the scheme, HBs are indicated by dashed lines between the atoms involved, while HCs are 
represented by an arc with spokes radiating towards the ligand atoms they contact. The other adducts are 
reported in Fig. C1 and Fig. C2 of Appendix C. 
 
2D heteronuclear NMR methods[134,141], in which 1H nuclei are correlated with 15N 
[134], are widely used to investigate structural aspects of intrinsically disordered proteins 
and their binding with ligands [142,143]. In some cases, these techniques are coupled 
with Paramagnetic Relaxation Enhancement (PRE) measurements [303]. Heteronuclear 
Multiple Quantum Correlation (HMQC) recorded with Selective Optimized-Flip-Angle 
Short-Transient (SOFAST) [144] improves the measured resolution of the spectra 
[142,144]. Particularly useful are the 2D HMQC and HSQC experiments, which permit to 
detect correlations between nuclei of two different types, separated by one bond. It is in 
general possible to assign heteronuclear chemical shifts even for proteins of up to several 
hundred aminoacids [8,304]. 
Unfortunately, interpreting changes in chemical shifts or peak intensities upon ligand 
binding for IDPs is challenging. In all of these methods, spectral changes can be caused 
by a variety of contributions. They may arise from conformational transitions associated 
	  	  
64	  
with long-range effects [8], chemical exchanges [141], molecular interactions (including 
those caused by direct contacts formed between the protein and the ligand), and possible 
interactions with weakly populated secondary products of the ligands, which may modify 
residues' conformations [305].  
Computational methods may be of great help to dissect contributions to NMR chemical 
shifts arising from direct ligand contact vs. conformational changes [306,307]. These 
methods have been applied so far to structured protein-ligand interactions. Here we 
attempt to extended the domain of applicability of computational methods to an IDP such 
as AS, by developing an apt computational tool for this class of proteins. This tool uses 
molecular dynamics (MD) trajectories as an input. A comparison between calculated and 
experimental NMR chemical shifts (CSs) and residual dipolar couplings (RDCs) is used 
to establish the accuracy of the method. The tool helps in the interpretation of CS changes 
in 2D 1H−15N NMR spectra (some of which are measured here) on passing from AS to 
the AS·DOP complex in an aqueous solution. 
 
5.2 METHODS 
	  
5.2.1 Experimental setup 2D 1H-15N Heteronuclear Single Quantum Correlation  
Plasmid pT7-7 encoding for human wild type AS (courtesy of Prof. Peter Lansbury Jr.) 
was expressed in E. coli BL21 (DE3) Express grown in M9 minimal medium 
supplemented with 15N-NH4Cl (Cambridge Isotopes Laboratories Inc.) as previously 
described [308]. AS was not N-terminally acetylated. After anion exchange purification, 
AS was further purified by size exclusion chromatography using buffer 20 mM phosphate 
150 mM NaCl pH 6.4. Peak fractions corresponding to the monomeric form of the protein 
were collected and used for NMR measurements. 1H-15N SOFAST-HMQC NMR spectra 
of AS in the free state and adduct between AS and DOP (dopamine and products of its 
oxidation cascade formed during the experiment, Fig. 5.1B) were recorded at 303 K on a 
Bruker Avance 750 MHz, equipped with cryogenically cooled triple resonance 
1H{13C/15N} TCI probes and z axis self-shielded gradient coils. SOFAST-HMQC pulse 
sequences were used [144]. Reference spectrum of free AS was recorded on 300 µl of 
200 µM uniformly isotope labeled protein. For AS•DOP NMR measurement, 10 mg of 
dopamine hydrochloride powder (Sigma) were dissolved in the AS solution previously 
used for acquisition of reference spectrum. The final concentration of DOP was 175.8 
mM. A pH decrease resulting from DOP addition (from 6.4 to 6.2) was corrected with 1 
µM NaOH before NMR measurement. Acquisition, processing, and spectra analyses were 
performed with TOPSPIN 2.1 (Bruker) and iNMR 3.6.3. Mean weighted chemical shift 
variations Δcs per residue read:  
Δcs = [(ΔH)^2 + (ΔN/10)^2]^0.5                                             (5.1) 
where Δ indicates the difference between the chemical shift between the bound and the 
free state, given for each backbone amide. Only well-resolved, non-overlapping AS 
signals were considered for the analysis. 
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5.2.2 MD simulation computational details 
The calculations are based on experimental AS structural ensemble obtained by NMR 
combined with PRE measurements [30]. AS is not N-terminally acetylated [46,309]. The 
six representatives of the most-populated clusters used here cover almost three quarters of 
AS conformations in the free non acetylated form {Herrera, 2008 #115;Dedmon,  
#69;Losasso, 2011 #187}. The initial configurations of adducts between AS and 
dopamine and its derivatives in Fig. 5.1B were obtained by docking the ligands onto the 
six representatives [132]. The minima characterizing these representatives may not 
dramatically change in the presence of the ligands. Each of the 36 adducts of AS•DOP 
[132] underwent 40 ns of classical molecular dynamics by NAMD 2.7 program [228]. 
The AMBER99SB [29] force field with ILDN modification [37,38] was used to describe 
the biomolecules and the counter ions, and the TIP3P [310] force field was employed for 
water molecules. The systems were embedded in a water box chosen so as to have a 
minimum distance of 10 Å between all protein atoms and the edge of the box. The 
number of water molecules in each box ranged between 76.842 and 184.638. The overall 
charge of the system was neutralized by adding 9 Na+ ions. Periodic boundary conditions 
were applied. During the simulations, the distance between the edge of the box and the 
nearest atom ranged from ~10 Å to ~25 Å. The distance between an atom and its images 
turned out to be always greater than ~17.5 Å (see Appendix Tab. C1). The simulations 
were performed at a temperature of 300 K and a preassure of 1,013 bar by coupling each 
system with a Langevin thermostat [245] having a coupling coefficient of 5 ps−1, and a 
Nosé-Hoover Langevin barostat [249] with an oscillation period of 200 fs and a damping 
timescale of 100 fs. Electrostatic interactions were calculated by using the Particle Mesh 
Ewald method [311]. The time-step was set to 2 fs. The SHAKE algorithm [312]  was 
applied to fix all bond lengths. We verified the stability and the convergence of the 
trajectories (see Appendix Tab. C2).  
5.2.3 MD derived calculated properties 
All the properties here reported were calculated considering only the frames in which 
DOP are linked to the protein. Hence we first detect the (i) Persistency of binding (P) 
here defined as the number of frames in which DOP form Hydrogen Bonds (HBs), 
Hydrophobic Interactions (HCs) or Salt-bridges (SBs) with AS, divided the total number 
of frames (Tab. 5.1). In details HBs are assumed to be formed if the distance between the 
hydrogen atom and acceptor is less than 2.7Å (i.e. the distance between the donor and 
acceptor is less than 3.3Å), and if the angle between the donor-hydrogen-acceptor and the 
hydrogen-acceptor-atom was greater than 90°.  AS•DOP HCs are assumed to be formed 
if the distance between carbon and/or sulfur atoms in AS and DA is smaller than 4 Å. 
DOP SBs are assumed to be formed if the distance between ammonium group in the 
positively charged molecule of dopamine DOPH (which bears a +4 charge) and AS 
carboxylic groups is less than 3.5 Å. See Tab. C3 for details. 
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P (%) DOP DOPH DCH DHI DQ IQ 
1 40 100 95 68 30 37 
2 40 20 100 100 20 100 
3 46 100 100 43 30 85 
4 22 100 100 100 30 3 
5 100 100 100 100 37 100 
6 12 65 6 18 30 25 
Table 5.1 Persistency (in %) of the formation of DOP non-covalently bound to AS in the AS•DOP 
representative conformers (1, 2, 3, 4, 5, 6 in the Table) during the MD simulations carried out in this work. 
 
The following properties were calculated and averaged over the MD trajectories for each 
configuration of the six adducts.  The symbol of average was omitted for the sake of 
clarity. 
(ii) The percentage of secondary structure elements (SS) was calculated as in [313].  
(iii) The end-to-end (E-E) distance was defined as the distance between the N atom of the 
residue 140ALA and the N atom of the residue 1MET.  
(iv) The gyration radius (Rg) was calculated as: 
                                                                                                      (5.2) 
where mi is the mass of atom i and ri the position of Cα atom i respect to the center of 
mass of the protein.  
The following properties were instead averaged over the MD simulations (for AS and 
AS•DOP) by considering the six configurations altogether. The weight of each 
configuration in the total average was established by the persistency of binding (P). For 
these quantities we use an “over line” for distinguishing them from the previously defined 
quantities, averaged only over the trajectory of the single conformation. 
(v) The frequency of AS•DOP hydrogen bond (HB) and hydrophobic contacts (HC) 
 was defined as the total number of contacts (no contacts) of the i-th residue in 
the configuration j of AS•DOP  
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                                       (5.3) 
 (vi) The difference  was  defined as: 
                              (5.4) 
where   and   are the (PADcum)ω values for the average on 
AS•DOP adducts and the free AS, respectively.  
(vii) Chemical Shift and Residual Dipolar Couplings. For AS, we calculated the C, Cα Cβ 
and N chemical shifts (CSs) using the program SHIFTX [314] and H-N residual dipolar 
couplings (RDCs) using the program PALES [315]. For AS•DOP, we calculated N 
chemical shifts with the same methodology.  
 
5.2.4 Statistical tools 
(viii) Statistical difference between AS and AS•DOP trajectories. We have demonstrate 
that TAIω  is able to quantify the amplitude of the residues’ movements. Here, this fact is 
exploited to distinguish AS from the AS•DOP trajectories. We use the multivariate 
analysis technique [280].   
The TAIω values for each of the 140 residues were calculated for the 42 MD trajectories 
generated in this work (6x6 for AS•DOP plus 6 for AS). These values were collected in a 
(42x140) matrix. The matrix underwent a principal component analysis (PCA) [280]. We 
used the MultiSpectra program [316]. The 95% confidence ellipses in the score plot of the 
two principal components was calculated [317]. TAIω values were averaged over the 
residues of the six configurations belonging to the same adduct (TAI’ω).  
The p-value [317] was calculated for each pair of adducts from the so-called cumulative 
F-distribution function [317]. P-value quantifies the probability of the hypothesis that 
assumes that AS belongs to the same conformational ensemble of AS•DOP adducts.  
(ix) Profile histograms between our measured Δcs (X variable hereafter) and  
or  (Y variables hereafter) were calculated as follows. The (X, Y) pairs for each 
residue were divided into four bins, on the basis of the Δcs values. The size and the 
number of the bins were chosen different for the C-terminal+NAC and N-terminal 
regions, taking into account the fact that the residues with higher Δcs belong to the C-
terminal and the residues with lower Δcs belong to the N-terminal. Next, the sample 
mean of Y (<Y>) in each bin was plotted against the midpoint of the corresponding Δcs 
freqC =
100*
(n!contacts)ij
i=1
nk
!
j=1
6
!
nk
(n!contacts)ij
i=1
nTOT
!
j=1
6
!
nTOT
!(PADcum )
!(PADcum ) = (PADcum )"AS•DOP # (PADcum )"AS
(PADcum )!AS•DOP (PADcum )!AS
!(PADcum )
freqC
	  	  
68	  
bin. The error for <Y> is its standard deviation divided by the number N of data pairs 
belonging to the considered bin. The plots were fitted to a trend line.  
(x) The Pearson’s correlation coefficients (CC) [318] measures the linear dependence 
between the X and Y variables.  
      (5.5) 
where <X> and <Y> are the sample means and sX and sY are the sample standard 
deviations of Δcs and  or , respectively, and N is the sample size, i.e 
the number of residues in the considered region [285]. The relative error reads:  
      (5.6) 
CC ranges from +1 (X and Y are directly correlated) and −1 (Δcs and Y are inversely 
correlated). If CC=0, X is not correlated with Y.  
(xi) A probability test is performed on the correlation values. We used the Fischer's Z-
transformation of the CC values [319], defined as: 
     (5.7) 
with standard deviation  
     (5.8) 
Unlike CC, Z follows a normal distribution. It is then possible to calculate its z-score 
[320], which provides a measure of the distance in standard deviations of the actual Z 
value from its mean value. The probability of finding a value of Z that is higher than the 
actual value is given by the area under the normal curve. 
 
5.3 RESULTS 
	  
5.3.1 MD simulations 
The MD simulations on adducts between AS and dopamine and its derivatives, AS•DOP 
hereafter (six configurations for six ligands, 36 systems in total, see Fig. 5.1B and Fig. 
5.2), in aqueous solution are an extension of our previous work, reported in ref [132]. 
They are based on AS experimental structural ensembles in aqueous solution obtained by 
NMR combined with PRE measurements [30,39]. Specifically, we used the six AS 
configurations representing the 73% of the overall experimental population [132]. The 
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initial configurations of the AS•DOP adducts were obtained by docking the six ligands of 
Fig. 5.1B onto the six AS representatives [132].11   
 
Figure 5.2. Representative structures obtained through a clustering analysis of an ensemble of ~4000 NMR 
structures of the AS. Figure created using the VMD program package. 
 
Here we extend our simulations time to 40 ns for each conformer. Several non-standard 
quantities described in the Methods, previous paragraph are calculated.  
 
5.3.2 Comparison with experiments and validation of the sampling. 
We compared CSs and RDCs calculated from our simulations on AS with experimental 
CSs of AS coming from three different experimental data sets from refs  [41,43,44]  also 
used in refs [40,42] (Fig. 5.3 A-C) and with experimental H-N RDCs of AS described in 
[42] (Fig. 5.3D). The high correlation between the calculated and experimental CSs (R2 > 
0.8) and between the calculated and the experimental RDCs (R2 ~ 0.8), shown in Fig. 5.3, 
validates our models. Comparison between CSs calculated from our simulations on 
AS•DOP and our corresponding experimental CSs on N atoms also show a good 
correlation (R2  ~  0.8)  (Fig. 5.3E). This points to the reliability also of the models of the 
adducts also. 
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
11 6ns MD simulations were carried out on each conformer. These turned out to be consistent with a variety of in vitro 
experiments on AS•DOP [292-294]. The main results of this previous study are: (i) DOP form stable contacts to AS and 
bind to the 125YEMPS129 region (ii) the ligands are further stabilized by long-range electrostatic interactions with glutamate 
83 (E83) in the NAC region, (iii) mutations at the 125YEMPS129 region do not affect AS aggregation, which is consistent 
with the fact that DOP interacts nonspecifically with this region. 
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Figure 5.3 (A-C) Comparison between calculated and experimental CSs of the C, Cα Cβ and N atoms of 
AS. Three experimental data sets are considered [43] [41] [44] which are also used in [40,42]. The 
comparison is with reference [44] in panel A, with reference [41] in panel B and with reference [43] in 
panel C. The data were retrieved from the Biological Magnetic Resonance Data Bank (BMRB) [321] with the 
code #16300 for A, #6968 for B and #17665 for C respectively. (D) Comparison between calculated and 
experimental H-N RDCs of AS. The experimental data set in reference [42] is considered. (E) Comparison 
between N CSs of AS•DOP calculated from our simulations and experimental CSs measured in this paper. 
 
We conclude that, in spite of the relatively short time scale investigated, our MD 
simulations of AS and AS•DOP are consistent with NMR data so far reported. This might 
suggest that the conformations sampled in our MD simulations reproduce to a good extent 
a significant portion of the experimentally sampled conformations.  
Several C-terminal residues, mainly located in the 125YEMPS129 region, establish specific 
hydrogen bonds (HBs) and hydrophobic contacts (HCs) with DOP (Tab. 5.2). 
 
 
 Tot HB/n res tot HC/n res 
N-terminal (1-60) 7 6 
NAC (61-95) 10 8 
C-terminal (96-140) 35 22 
YEMPS (125-129) 47 63 
Table 5.2 Calculated frequency of hydrogen bonds (HB) and hydrophobic contacts (HC) for specific 
regions of the protein, averaged over the 6 representative configurations of AS•DOP, normalized with 
respect the number of residues belonging to each region. 
 
A graphical representation of the molecular details of such interactions is offered in 
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Figure 5.1C (along with Figures C1 and C2 in the Appendix C), which report MD 
snapshots of the adducts between DOP and AS. Our findings are consistent with 
previously published 2D 1H-15N HSQC spectra [143], and in vitro and in vivo 
experiments [132,292,293,295], which suggest the presence of non-covalent DOP 
interactions mainly in the 125YEMPS129 sequence.  
Ligands binding causes an increase in the overall number of residues involved in 
secondary structure elements in all the conformers of AS•DOP (Tab. 5.3).  
  SS % 1 2 3 4 5 6 Average 
DOP α-H 6 4 0 4 3 1 3 
  β-s 0 4 23 0 1 0 5 
  T 24 20 1 23 19 15 17 
  BB 1 1 0 2 2 1 1 
  TOT 31 29 33 28 24 17 27 
DOPH α-H 3  1 2 3  3  2 2 
  β-s 1  1 0  2 2  1 1 
  T 23  20 20 23  14 19  20 
  BB 3 2  1  0 0  1 1 
  TOT 30  24 23 28  19 23  25 
DCH α-H 1 4 7 4 4 3 4 
  β-s 0 0 0 0 1 1 0 
  T 25 20 23 19 16 22 21 
  BB 2 1 1 0 2 2 1 
  TOT 28 25 31 24 23 28 26 
DHI α-H 5 4 1 8 5 1 4 
  β-s 0 1 4 0 1 1 1 
  T 24 16 15 15 21 14 17 
  BB 1 2 1 0 2 2 1 
  TOT 30 22 20 27 28 18 24 
DQ α-H 5 2 3 3 3 3 3 
  β-s 2 2 2 0 2 0 1 
  T 24 18 17 9 11 18 16 
  BB 2 2 1 2 3 1 2 
  TOT 32 27 22 14 20 22 23 
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IQ α-H 4 3 3 5 1 2 3 
  β-s 0 2 0 0 1 1 1 
  T 22 14 19 23 15 20 19 
  BB 1 0 1 1 2 3 1 
  TOT 27 18 23 29 18 26 23 
AS (no ligand) α-H 6 2 2 1 2 1 2 
  β-s 1 10 9 1 3 1 4 
  T 17 12 15 11 14 11 13 
  BB 2 0 1 3 3 2 2 
  TOT 26 24 28 15 21 14 21 
Table 5.3 Secondary Structure (SS) percentage of AS•DOP and AS 6 representative configurations (1, 2, 3, 
4, 5, 6 in this table) average over the MD simulation time. The total percentage (TOT) and specific secondary 
structure content (%SS) are indicated as α-H (α-helix), β-s (β-sheet), T (turn), BB (B-bridge). The β-s and 
the TOT content are underlined in bold italics. 
In  particular, the α-helix and β-turn contents increase and the β-sheet content decreases 
for AS•DOP adducts relative to AS. The decrease in β -sheet content has also been 
observed in circular dichroism experiments (CD) with AS in the presence of DOP 
reported in refs [132,295,322].  The observed decrease in β-sheet content may reflect the 
ligands’ efficacy in preventing the formation of oligomeric species. A clear trend is 
instead not identified for the end-to-end distances (Appendix C4 Tab. C4) and the Rg 
(Appendix C4 Tab. C5) of AS•DOP. The average value of Rg of free AS is consistent 
with structural characterizations of AS with PRE-NMR spectroscopy experiments in 
[30,39]. These studies report a Rg value of 27.2 Å that compares well with our values for 
the three representatives of the most populated clusters, 24.8±7.4, 28.0±4.1 and 27.5±3.9 
Å (Appendix C4 Tab.C5). However this agreement cannot be taken as a validation. 
Indeed, several different values of Rg of human AS (at neutral pH and room temperature) 
have been inferred based on SAXS [322-325], PRE-NMR [8,30,324,325]and Single 
Molecules Fret [326] experiments. These values range widely, from ~22 to ~40 Å (See 
Appendix C4 Fig. C3 and Tab C6).  
 
5.3.3 NMR measurements 
The changes in NMR chemical shifts upon DOP binding (Δcs, defined in Methods 
Section, Fig. 5.4) are observed for nearly all of AS protein residues. The largest Δcs are 
associated with the C-terminal and in particular with the 125YEMPS129 region.12 This 
result is similar to what was found in reported HSQC spectra [143].  
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
12 In details the residues in decreasing order with respect to their Δcs value are Y125, E137, S129, E126, D119, L113, 
V118, M116 and relative Δcs’s values are 1 ppm, 0.89 ppm, 0.88 ppm, 0.79 ppm, 0.77 ppm, 0.62 ppm, 0.60 ppm, 0.58 ppm 
respectively. 
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Figure 5.4 AS NMR chemical shift variation upon DOP addition. Top: overlay of 1H-15N SOFAST-HMQC 
spectra of free AS (blue) and AS•DOP (red). Measurements were performed at 303 K on a 200 µM AS sample 
in buffer 20 mM sodium phosphate, 150 mM NaCl pH 6.4, and with 10 mg DOP. Well-resolved AS amide-
resonances that display prominent chemical shift changes upon DOP addition are indicated. Bottom: Mean 
weighted chemical shift changes (Δcs) calculated from NMR spectra. 
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We propose here that DOP mainly binds at the C-terminal region, preferentially to the 
125YEMPS129 residues. Hence the largest Δcs values observed in the spectra should be 
mostly caused by non-covalent interactions (i.e. contacts) between AS and the ligands. 
This hypothesis is fully consistent with MD analysis and available experimental data 
[132,143,292,293,295]. Moreover, molecular and biochemical approaches, including 
mutagenesis and competitive binding experiments, also identify the 125YEMPS129 region 
of AS as crucial in the DOP induced inhibition of AS fibril formation [132,292,293,295].  
We test our hypothesis by performing a graphical and statistical analysis on the quantities 
Δcs and frequency of contacts ( ) between DOP and AS residues during our MD 
simulations (for a definition of  see Method section). 
The degree of correlation between the Δcs and  is estimated using the Pearson’s 
correlation coefficient (CC) [318] and the statistical z-score [320]. The former is defined 
in a way that when -1 ≤ CC < 0 it shows an inverse correlation, while CC=0 reveals an 
absence of correlation and 0 < CC ≤ 1 a direct correlation. The latter ranges between 0 
and 100%. The closer the z-score is to 100%, the higher the probability of a strong 
correlation between the two quantities. Figure 5.5 reports the profile histograms between 
our experimental observable Δcs and  for the N-terminal and the C-terminal+NAC 
regions.  
Interestingly,  correlates with Δcs at the C-terminal region (Fig. 5.5 A-B). The 
correlation is extended also to the NAC region, but not to the N-terminal. Although the 
interactions between DOP and NAC region are minor, some specific residues (i.e. V66, 
A69, S87) show significant changes in Δcs (0.018 ppm, 0.014 ppm, 0.013 ppm 
respectively). These could be caused by specific interaction with DOP. In the C-
terminal+NAC region the CC value between Δcs and  is positive (CC= 0.43±0.10 
Fig. 5.5B) and the z-score is 68% (Tab. 5.4).  
z-score (%) N-terminal NAC+ C-terminal 
Δcs /  60 36 
Δcs /  55 68 
Table 5.4 Z-scores (in %) for the correlation analysis between  and Δcs and between   
and Δcs in the N-terminal and NAC+C-terminal regions of AS•DOP. 
In contrast, the plot between Δcs and  at the N-terminal does not have a defined 
trend. Consistently, CC is close to zero (Fig. 5.5 A).  
However, few residues with relatively large Δcs are observed in this region. These 
include G14, T22, K32, K43 and F4. These residues do not form contacts with the 
freqC
freqC
freqC
freqC
freqC
freqC
!(PADcum )
freqC
!(PADcum ) freqC
freqC
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ligands. A visual inspection of the protein conformations during the dynamics, lead us to 
suggest (albeit it does not prove) that these Δcs at the N-terminal might be partially 
induced by conformational transitions upon DOP binding. DOP was shown to induced 
conformational changes in AS expressed in neuronal cell lines [327]. Hence we 
investigate whether these chemical shift changes are caused, at least in part, by 
conformational transitions. The latter can be detected with the Cumulative Protein 
Angular Dispersion,  (see Methods section and Appendix C Fig. C4). The 
higher the , the more the residue experienced conformational rearrangements 
when passing from the free form to the bound form. Figure 5.5 C-D reports the profile 
histograms between our experimental observable Δcs and  for the N-terminal 
and the C-terminal+NAC regions. and Δcs turned out to be correlated at the 
N-terminal (Fig. 5.5C). Indeed, both quantities grow evenly, and in addition, the CC is 
positive (CC= 0.24±0.17 Fig. 5.5C) and the z-score is 60% (Tab. 5.4). This indicates a 
direct correlation between the  and Δcs in this region. Therefore, the Δcs at 
the N-terminal may be induced by conformational transitions upon DOP binding. 
Next, we examined the relationship between  and the Δcs at the C-terminal. 
The trend line shows a negative slope and CC is negative. The higher Δcs values, the 
lower is . This might suggests that the residues involved in the binding have 
reduced degrees of freedom (Fig. 5.5D). 
!(PADcum )
!(PADcum )
!(PADcum )
!(PADcum )
!(PADcum )
!(PADcum )
!(PADcum )
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Figure 5.5 Profile histograms:  (A, B) and  (C, D) are plotted as a function of Δcs for 
the N-terminal (1-60, A, C) and NAC + C-terminal region (61-140, B, D). Each point represents the couple of 
values: X equal to the middle point of the Δcs bin, Y equal to the mean values of the  (A, B) or 
 (C, D) calculated on the residues belonging to the corresponding bin. The horizontal lines 
represent the bin size and the vertical lines represent the error on the mean value of the Y variable (see 
Methods). Notice that the last bar error in B panel is larger respect the others, since the residues belonging 
to the last Δcs bin show an high variability in the  values: specifically the 125YEMPS129 residues have 
the highest values of  but neighbor residues have lower values. Best-fit lines are plotted in green, and 
the values of their slopes are reported. The CC values with relative error for each plot are reported. 
 
Other contributions to the Δcs may include the interactions of N-terminal residues with 
weakly populated products of the oxidation cascade of dopamine, as well as the oxidation 
of the MET residues in positions M1, M5, M116 and M127, due to the long incubation 
periods with dopamine [143,328].  
 
 
freqC !(PADcum )
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5.3.4 Statistical differences between AS•DOP's and AS' trajectories 
The so-called Transition Amplitude index TAIω, which quantifies the amplitude of motion 
for each residue (see Chapter 3 Statistical tools), turned out to be larger for AS than 
AS•DOP (Tab. 5.5, Fig. 5.6, Fig. 5.7A).  
 
 DOPH IQ DCH DOP DHI DQ AS (no ligand) 
TAIω’ 75.1° 68.0° 89.2° 68.7° 67.4° 67.4° 104.3° 
p-value 0.365 0.52 0.158 0.436 0.479 0.494 0.045 
Table 5.5 Classification of results. TAIω values averaged over the residues for each configuration belonging 
to the same adduct (TAIω’); p-values for null hypothesis. See Method Section for details. 
A PCA analysis of the TAIω values show that the first principal component (PC1), which 
captures the 24.7% of total variance13, separates most AS configurations (which have 
positive PC1 values)  from the AS•DOP ones (which have negative PC1 values) (Fig. 
5.6). Thus, the data projected into PC1 form two clusters: those with positive PC1 values 
ranges from 40° to 160° uniformly for all the residues, while those with negative PC1 
values ranges from 20° to 100° for most of the residues. The only exceptions are four 
representative configurations of the AS adduct with DCH and two representative 
configurations of the AS adduct with DOPH. 
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
13 The second component (PC2) captures the 6% of total variance. 
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Figure 5.6 Distributions of TAIω: The distributions of TAIω as a function of residue number are shown for 
AS and AS•DOP adducts for each configuration. They are divided in two groups: the first (top) has positive 
values of the first principal component (AS, configurations 2 and 4 of AS•DOPH, configurations 1,2,3 and 4 
of AS•DCH) and the second (bottom) has negative values of the first principal component. A red line is 
drowned on the plots in correspondence of 100 degrees, for underlining the different behaviors of the TAIω 
values of the two ensembles.  
Graphically, the statistical significant separation is shown by calculating the 95% 
confidence ellipses [317] in the score plot of the first two principal components (Fig. 
5.7B). The six AS trajectories are well separated from those of AS•DOP (Fig. 5.7B), 
except for two configurations of the adducts with DOPH and four configurations of the 
adducts with DCH.  
 
Figure 5.7 Statistical significance of DOP-induced structural perturbations (A). The TAIω values for each 
residue in AS and AS•DOP (See Methods for a definition of this quantity) is colored according to its value. 
The violet color corresponds to the lowest values. The red color corresponds to the largest values. (B) Score 
plot [317] in the first two principal components of the matrix of the TAIω values (PC1 and PC2). The 
percentage of their variance is reported on the correspondent axis. Each point represents a simulated system. 
Each group of point has the same color according to the system they represent (either AS or one of the 6 
AS•DOP adducts). 95% confidence ellipses [317] are drawn for each group. 
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The so-called p-value [317] for each pair of residues, which quantifies the probability of 
the hypothesis that assumes that AS belongs to the same conformational ensemble of 
AS•DOP adducts, turns out to be below 5% (Tab. 5.5).   
All of these evidences lead us to conclude that the spectrum of configurations visited by 
AS is substantially different from those observed for the AS•DOP adducts. In other 
words, the MD trajectory of AS•DOP adducts are not a reproduction of free AS 
trajectories, and they are able to capture the DOP binding effects with a statistical 
significance. 
 
5.4 CONCLUSION AND DISCUSSION 
 
We have presented a MD-based interpretation of 2D 1H−15N HMQC spectra of AS•DOP 
adducts. Our analysis leads us to suggest that Δcs at the C-terminus and at few residues in 
the NAC region (i.e., V66, A69, and S87) may be mostly caused by non-covalent contacts 
with the ligands, which is consistent with molecular and biochemical approaches 
[132,292,293,295] and 2D 1H−15N HSQC spectra [143]. We further suggest that the Δcs 
changes upon binding of DOP at the N-terminus are due, at least in part, to 
conformational rearrangements of the N-terminal residues. Consistently, DOP was shown 
to induce conformational changes in AS by fluorescence lifetime imaging microscopy in 
primary neuronal cultures [327]. Importantly, the simulations of AS and AS•DOP are 
significantly different, as shown by a statistical analysis performed here. Notably, they 
are consistent with the experimental CSs [41-44]and RDCs [42] for AS reported so far as 
well as with the experimental CS of AS•DOP reported in this paper. This establishes the 
quality of our models for the protein both in the free state and in complex with DOP.  
 
5.4.1 Limitations of the Molecular Modeling Procedure.  
As in any modeling study, the computational procedure presented here has several 
limitations. First, the performed simulations do not focus on the binding event between 
AS and DOP, but only the final structural ensemble of the AS·DOP adducts[132].Second, 
biomolecular force fields such as AMBER have been constructed for structured proteins, 
so their domain of applicability to intrinsically unstructured proteins such as AS remains 
to be established [24,25,39]. However, our current and previous[132] studies seem to 
suggest that for the specific case of AS, MD simulations with the AMBER99SB force 
field are able to reproduce the available experimental data. Third, the time 
scale investigated by simulation of AS and AS·DOP is several orders of magnitude lower 
than that of NMR and other biophysical experiments to which comparisons have been 
made. 
Indeed, with the present computational power, it may be very difficult, if not impossible, 
to cover with MD the immense conformational space explored by AS in solution if one 
starts from a random conformation. However, a crucial point here is the fact that our MD 
simulations are based on AS experimental structural ensembles obtained by NMR 
combined with PRE measurements [30,39]. This allowed us to use six AS configurations 
representing 73% of the overall experimental population [132]. Indeed, simulations of 
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these “representative” structures and adducts with small molecules may sample free 
energy minima associated with conformations not too dissimilar from experimental 
conformations. In agreement with this hypothesis, our calculations are fully consistent 
with the available CSs [41-44] and RDCs [42]  reported previously. Because of the 
limited time scale investigated, however, our interpretation of the NMR data can be taken 
only at the semiquantitative level. Finally, and most importantly, our modeling focuses on 
one AS molecule interacting with one of the compounds in Figure 5.1B. However, in the 
performed experiments, it is not possible to know the DOP derivatives with which the 
protein interacts. It is presumable that in the experiments one AS protein is interacting 
simultaneously with more than one oxidation product of dopamine, because its 
concentration is higher than that of AS. Cooperative effects due to multiple bindings 
could be present. 
In spite of these caveats, the fact that our simulations are consistent with all the available 
experimental NMR data [41-44] leads us to suggest that key aspects of the interactions 
between AS and DOP are captured by our study and, therefore, our MD simulations can 
be of help in interpreting the measured NMR data. 
 
 
 
 
 
 
 
	  	  
81	  
CHAPTER 6 
 
 
 
 
 
 
6. STRUCTURAL DETERMINANTS AND SPECTROSCOPIC PROPERTIES OF 
ACETYLATED Α-SYNUCLEIN: PRELIMINARY RESULTS. 
 
 
6.1 INTRODUCTION 
 
α-synuclein (AS) is the primary protein component in Lewy Bodies inclusions patients 
with Parkinson’s disease. Most of the biochemical and biophysical studies on the 
structure, aggregation, and function of AS in vitro utilize recombinant AS from E. coli, 
which is not N-terminally acetylated [329]. However, it has been recently discovered that 
in humans AS is acetylated at its N-terminal (Ac-AS) (Fig. 6.1) [45,309]14. This post-
translational modification affects the protein's membrane binding properties [48] by 
increasing its lipid binding affinity [46]. It also impacts on the structure of the N-terminal 
of AS in solution [309], as revealed by CD [45,46,48,309] and NMR [45,46,48]15 
spectroscopies, despite they found no evidence for a stable helical structure of the 
remaining Ac-AS structure concluding that the modified protein remained largely 
disordered. Both techniques (NMR and CD) showed that the α-helicity at the N-terminus 
increases on passing from AS to Ac-AS [45,46,48,309]. This may arise by the fact that 
the acetyl group masks the alpha-amino positive charge and interacts favourably with the 
helix dipole moment16. In addition, the NMR studies show that: (i) The N-terminal acetyl 
group affects the transient secondary structure of the protein [45,46,48]. Levels of 
detectable transient helicity rapidly diminished with increasing distance from the acetyl 
group[46]. (ii) The NMR chemical shifts of the first 9 [46] to 12 residues [45] change 
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
14 N-terminal acetylation is a well-known modification in eukaryotic cells [330,331]. Up to 80% of proteins in mammals 
are modified by N-terminal acetylation [331-333]. It occurs at the N-terminus, when an acetyl group removes the a-amino 
charge of the initiating amino acid by covalent modification at that site [334,335]. 
15 Acetylation may affect also  the membrane binding properties  of the protein [46]. 
16 Additionally, the acetyl group itself is a good N- cap, favoring hydrogen bonding for an N-terminal alpha helix at the 
initiating residues [336,337]. 
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relative to those in the non-acetylated form. Camilloni et al. [338] indicates a small but 
distinct increase in the population of α-helix near the N-terminus for the acetylated form 
of the protein. Specifically a 6% to 17% relative increase in α-helical content upon 
acetylation in the first 12 residues was detected. Moreover, Kang et al. [45] detected a 
small reduction in β-sheet propensities near residues 28–31, 43–46, and 50–66. (iii) The 
hydrodynamic radius and intra-chain long-range interactions are minimally altered 
[46,48]. 
Acetylation at the N-term may also affect fibril formation properties, although this issue 
is currently object of debate [45,46,48]. 
The conformational properties of Ac-AS in aqueous solution are thought to play a key 
role in the structural transition from the monomer to amyloid fibrils [45,339]. Hence 
characterizing Ac-AS conformational properties, which are clearly distinct from those of 
the non physiological form is crucial both to study the mechanism of fibril formation and  
to design rationally ligands that bind to the protein for anti-PD intervention [295,340]. 
Here, we provide a preliminary study on the structural determinants of the N-terminally 
acetylated AS conformational ensemble in aqueous solution by using an enhanced 
sampling method based on molecular dynamic simulations. Specifically, we used the 
latest version of the Replica Exchange with Solute Tempering method (REST2) [47] in 
explicit water. 
 
 
Figure 6.1 Structure of acetylated AS. This biologically active species of the protein is acetylated at the first 
residues of the N-terminal. N-termini (residues 1 to 60) with the imperfect KTKEGV repeats, the non-β-
amyloid component (NAC) (amino acids 61–95) domain and C-termini (amino acids 96–140), are also 
shown. 
 
6.2 COMPUTATIONAL DETAILS 
 
Six acetylated AS conformers (Ac-AS) were obtained from AS by adding the acetylic 
group to the N-terminal region (see Figure 5.1 in previous Chapter). This was achieved 
using Gaussview [341]. The six representatives structures of the non acetylated form of 
AS have been extracted from an ensemble of ca. 4,000 experimental NMR structures 
using a clustering analysis [342]. Altogether, these structures cover 73% of the 
conformational space of the protein structural ensemble [39]. 
The six Ac-AS representatives were placed in the centre of a water box using a 10-Å 
buffer zone of solvent around the protein. The Amber ff99SB force fields [29] with ILDN 
modification [343] for the protein and the TIP3P water model [310] was employed. 
Electrostatic interactions were calculated using the Particle Mesh-Ewald (PME) method 
[311]. All bond lengths was constrained by the LINCS algorithm [239] and an integration 
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step of 2 fs was set. The systems were geometry-optimized and then equilibrated at 300 K 
and 1 atm by performing 1 ns of gradual annealing and 1 ns of constant temperature 
relaxation using the GROMACS 4.5.5 program package [344]. Constant temperature and 
pressure conditions will be achieved by coupling the system with a Nose-Hoover 
thermostat [247,248] and an Andersen-Parrinello-Rahman barostat [250]. The 
conformations of the six the lowest effective temperature conformation of the proteins 
after the equilibration phase (2 ns in total) are reported in Fig. 6.2. 
 
Figure 6.2 MD snapshots of the six structures of acetylated AS obtained after 1 ns of equilibration at 
300K. The acetylic groups are highlighted. The starting NMR structure is reported in grey for each 
configuration. Figure created using the VMD program package [313]. 
 
 
Due to the large conformational space of the protein, we used an enhanced sampling 
technique, the Replica-Exchange Molecular Dynamics (REMD) [156,261,262]. In 
particular, we used one of its variant, the so-called Replica Exchange with Solute 
Tempering in its most recent implementation, REST2 [47]. In the latter only the protein 
and the ions (i.e. the solute) are simulated at different effective temperatures by applying 
an appropriate potential energy function to each replica [174]. This methodology is 
particularly suitable for systems as large as those considered here [47,263]. Each system 
is here composed by about 2,000 atoms for the protein and a variable number of water 
molecules, for a total number of atoms that ranges from 84,000 to 174,000 for the entire 
systems (see in Appendix D tab. D1). Despite the temperature, each replica has the same 
computational set-up discussed above. 
Identifying the minimum number of replicas17 and their effective temperatures giving a 
good exchange probability among adjacent replicas is the biggest challenge in setting up 
REST2 simulations (Appendix D, Fig. D1). 
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
17 Increasing this number increases the computational cost. 
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Obviously, the maximum effective temperature is the one in which the protein starts to 
change dramatically its structural features [156,174,261]. Calculations performed here 
suggest that this temperature is ca. 500 K18. The minimum temperature can be taken 
similar to that of in vitro experiments. In this case, it set to 300 K. After several different 
trials, the estimated number of replica between 300 K and 500 K has been set up at 3219, 
which permit an efficient exploration of the conformational space, following ref. [268]. 
We estimate that the exchange probability between adjacent replicas is ~40% and for all 
of the replica pairs  (Fig. 6.3). 
 
Figure 6.3 Distribution of the potential energy for replicas with different 32 effective temperatures of the 
protein, each of one run for 400 ps. The potential energy is calculated as follow: Epp + (1/2)(Tm/T0)1/2Epw, 
where Epp and Epw are the protein intramolecular energy and the interaction energy between the protein and 
water, respectively; while T0 and Tm are the effective temperature of the lowest temperature replica and of the 
m-temperature replica, respectively. 
 
Therefore we plan to perform 10 ns-long REST2 simulations for each of the six Ac-AS 
systems by using 32 replicas. Up to now we have the first 2 ns of trajectory for each 
system. 
 
6.3 PRELIMINARY RESULTS 
 
We have analysed 2 ns of trajectories for each representative. The following quantities 
were calculated: 
 
 
 
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
18 Such value has been obtained by running 1 ns of gradual annealing from 300 K to 500 K: we indeed observe that the 
secondary structure content and the gyration radius of the protein changes dramatically approaching 500 K. The value of 
500 K is the same as that set in previous replica exchange studies on fragment of the protein [156,174,261]. 
19 This value is larger than that used in previous studies on Ac-AS with replica exchange techniques [345,346]. 
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(i) Chemical shifts  
Calculated HN, Hα, Cα, Cβ and N chemical shifts (CSs) were compared to the 
experimental ones (at 1 bar pressure) [347] (Fig. 6.4). using the program SHIFTX [314]. 
The correlation between the average CS calculated over our trajectories and experimental 
CSs (R2 ~ 0.548) is shown in Fig. 6.4 for the first representative (the others are reported 
in Appendix D2 Fig. D2 ). The low correlation is likely to arise (at least in part) by the 
fact that the investigated time scale is short and our MD simulations of Ac-AS are not yet 
converged. Longer calculations are required to address this issue. 
 
Figure 6.4 Comparison between calculated and experimental CSs of the Hα, HN, Cα Cβ and N atoms of 
Ac-AS cluster 1. The experimental data set considered is reported in the supporting information of ref [347]. 
The CSs calculated from the average trajectories are depicted with blue dots, the ones from the best frame 
trajectories with red dots.  
 
(ii) The radii of gyration (Rg). In AS the Rg vary from 2.2 to 4.2 nm 
[8,30,50,98,322,323,325,326]. Ac-AS has been reported to feature Rg values slightly 
larger than AS [46,48]. From our simulations of AS without acetylation we found Rg 
values ranging from 2.4 to 2.8 nm [348]. In our simulations of Ac-AS we found an Rg 
ranging from 2.5 to 5.5 nm (Fig. 6.5). 
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Figure 6.5 Radius of gyration (Rg) vs. time plots calculated for the lowest-effective temperature replicas 
(300 K) for all the Ac-AS systems. 
(ii) Secondary structure content. The 2nd and 4th representatives, at the first 10 residues, 
show the presence of a small amount of α-helix (Fig. 6.6), revealed from experiments at 
the N-term [45,46,48,309]. The other clusters do not. This again could be a result of 
limited sampling. Longer simulations are required to address this issue.  
Figure 6.6 Secondary structure content versus time plots calculated for the lowest-effective temperature 
replicas (300 K) for all the Ac-AS systems. For details information see Appendix D (Figure D3 and Table D2- 
D3) 
 
Others quantities related to the convergence of the trajectories are reported in Appendix D 
section D4. 
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6.4 FUTURE DEVELOPEMENTS  
 
We will extend the REST2 simulations to the time planned. This is required to get 
convergence of the results. At the present stage, the results are to be considered as 
preliminary. The results will be compared and validated by comparison with the NMR 
and the CD data [45,46,48,309]20. 
  
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
20	  for that, we are going to use the DichroCalc program suite [349] considering the semi 
empirical parameters of ref. [350]	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CHAPTER 7 
 
 
 
 
 
7. CONCLUSIONS 
	  
Intrinsic Disordered proteins (IDPs) are an important class of functional proteins with 
high abundance in nature [4,5,55,56]. Indeed about one-third of eukaryotic proteins are 
predicted to be IDPs [1]. It is now established that this class of proteins have fundamental 
roles in biology since they are frequently involved in crucial tasks such as signalling and 
regulation [50,55,351-353]. Notably IDPs are extensively associated with human diseases 
and amyloidosis [57,93]. Understanding their action is hence essential not only for basic 
biophysics but also for pharmacological applications. 
Unfortunately, the highly dynamic nature of IDPs[134], the presence of local and long-
range conformational rearrangements [7,354], transient secondary structure and transient 
long-range tertiary structure [6,8,355] poses challenges for drug design projects.  
Additional problems may arise from low overall hydrophobicity and high net charge 
[356]. From a computational point of view, further challenges are the sampling of the 
wide conformational space as well as the lack of a force field tailored for unstructured 
proteins [24,25].  
In this thesis, we attempted to address with computational methods some of these 
problematic aspects on IDPs investigation.  We focused on alpha synuclein protein, an 
IDP involved in Parkinson's disease. In the first part of my thesis I have proposed a 
computational protocol based on classical molecular dynamics (MD), using the Amber 
parm99SB force field [29] plus the ildn modification [37,38]. This protocol was used to 
investigate how the conformational space of alpha synuclein (AS) protein is affected by 
the binding of an anti-aggregation drug, dopamine (DOP)[34-36].  
To overcome the sampling problems associate with IDPs, I started our simulations from a 
conformational ensemble experimentally determined by NMR spectroscopy combined 
with paramagnetic Relaxation Enhancement (PRE) [30]. The quality of the models for the 
AS, in the free and in the bound state, has been carefully estimated by comparing 
experimental chemical shifts [40,41,43,44] and Residual dipolar couplings (RDCs) [42] 
with the ones calculated from our MD simulations for both the free AS and the AS bound 
to DOP. Moreover good agreement has been found on structural experimental quantities 
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as the secondary structure content [132,322,327] and gyration radius [30,39] for AS. 
Next, we analyze the conformational ensemble of AS, alone and in the presence of the 
drug, with a newly developed tool based on dihedral angle distributions. The latter 
represents an innovative aspect of my thesis: not only our tool is able to detect and 
quantify backbone conformational transitions in proteins; it is also able to quantitative 
detect the effects of the drug on the dynamical spectra of the protein. 
With our tool we were able to interpret 2D 
1
H-
15
N HMQC spectra (kindly provided by 
Philipp Selenko’s In cell NMR Laboratory (Leibniz Institute of Molecular Pharmacology 
(FMP Berlin), Department of NMR-supported Structural Biology, Berlin, Germany) of 
AS in the presence of the anti-aggregation drug.  Specifically we were able to distinguish 
variation of chemical shifts arising from conformational rearrangements of residues with 
respect the ones due to direct contacts with the drug.  
Next, I investigated the conformational space of AS in its acetylated, physiologically 
relevant form [45,309], for which no structural ensemble is available. The large 
conformational space of the protein in solution has been explored with an enhanced 
sampling technique, the latest version of the Replica Exchange with Solute Tempering 
(REST) method [47]. The optimal setup for AS system has been obtained. The 
preliminary analysis on the present stage of trajectories simulated shown good agreement 
with the experimental available data. These include gyration radii and secondary structure 
contents [45,46,48]. 
All the methods presented here helps the characterization of the structural determinants of 
IDPs and their interaction with drugs, providing crucial insights for possible therapeutic 
strategies through computational physics approaches.  
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APPENDIX 
A AS AND PARKINSON’S DISEASE  
Parkinson’s disease (PD) [357] is a progressive neurodegenerative disorder clinically 
characterized by severe motor impairment including bradykinesia, muscular rigidity, and 
resting tremor [358].  
Several genes including, AS, parkin, DJ-1, PINK-1 and LRRK2, have been identified and 
linked to PD. Mutations within these genes lead to the familial forms of PD. 
Multiplications of the gene encoding AS (SNCA) and various point mutations in this gene 
(A53T [359], A30P [360] and E46K [361]) result in dominant familial Parkinsonism. 
Moreover, certain polymorphisms in SNCA are major risk factors for sporadic PD. These 
diseases affect over 5 million people worldwide. Both environmental risk factors and 
genetic mutations in PD-linked genes have been associated with oxidative stress and 
mitochondria dysfunction and this could cause impairment of the proteasomal pathways 
leading to abnormal protein aggregation and ultimately PD.  
It is characterized by the selective loss of dopaminergic neurons in the substantia nigra 
region of the brain, with a reduction of these neurons occurring in PD patients [362]. 
Another key pathological characteristic of PD is the formation of intracytoplasmic 
inclusions, known as Lewy bodies, in various regions of the brain including the surviving 
neurons of the substantia nigra, composed of a large number of molecules, among which 
AS amyloid fibrils are the most prominent component [363]. The Lewy body is found in 
the cell body of the neuron rather than the neurites, despite both DOP and AS being 
present in the synapses of dopaminergic neurons [363]. This may reflect the requirement 
for certain buffer conditions or co-factors being present or absent to either inhibit or 
promote Lewy body formation.  
An increasing body of evidence from animal models as well as data from genetic, 
biochemical and biophysical studies support the hypothesis that the processes of AS 
oligomerization and fibril growth have central roles in the pathogenesis of PD and other 
synucleinopathies [364]. In addition, it is possible that the AS monomers might also have 
a role in synucleinopathies by their displacement from their physiological location, 
resulting in a loss of cellular function, or by disrupting the activity of other molecular or 
signalling pathways [The many faces of α ‐synuclein: from structure and toxicity to 
therapeutic target]. Nevertheless, the molecular mechanisms by which AS aggregation 
contributes to neurodegeneration, the nature of the toxic forms of AS and the cellular 
pathways that are affected by AS remain unknown.  
Addressing knowledge gaps will be crucial for understanding the molecular basis of 
synucleinopathies, developing tools to diagnose and monitor the progression of these 
diseases, and assessing the effectiveness of preventive and therapeutic strategies. 
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B MATHEMATICAL DERIVATIONS OF QUANTITIES DEFINED IN THE STATISTICAL 
TOOL CHAPTER 
 
B1 Derivation of formula (3.1) 
Eqs (3.1) and (3.2), applied to a time series constituted by only two angles ω 1 and ω 2, 
become 
 
.  (B1) 
 
If we use the phase shift between the two angles as unique variable, i.e. we put  
and  (CSω is invariant for rotations of the reference system, thanks to the 
properties of the vector sum), we can derive: 
 
,    (B2) 
 
which relates the value of CSω to the angular shift between the two angles. By inverting 
eq. (B2) we get 
 
,    (B3) 
 
which coincides with eq. (4.2) if we put  and consider CSω as the 
circular spread of the original time series constituted by N ωi values. Thus PADω turns 
out to represent the angle between two unit vectors that have the same circular spread of 
the N ωi values. Therefore it may be expressed in degrees and its values are within the 
interval [0°, 180°]: 0° meaning no spread (the unit vectors are aligned), 180° meaning 
maximum spread (the unit vectors are opposite and their resultant is zero). 
 
B2 Calculation of the Cumulative Protein Angular Dispersion 
(PADcum)ω is defined by eq. 4.4: it is a PADω index calculated on the time series of the 
cumulative angular values !!  . They represents the angles formed by the vectors !!!!!!!!  and can be calculated as: 
CS! =
2! (sin2!1 + sin2!2 )2 + (cos2!1 + cos2!2 )2
(sin!1 + sin!2 )2 + (cos!1 + cos!2 )2
01 =ω
ωω Δ=2
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          (B4) 
 
where sign is a function that return +1 or -1 according to the sign of its argument. 
 
B3 Definition and calculation of the Angular Transition Index 
The investigation about the memory of data in time series has been first accomplished by 
Hurst [365] and lead to the introduction of the rescaled range series, which measure the 
changes in the original time series as a function of the length of the time interval 
considered. For a scalar time series x1, x2,…., xN the rescaled range series is defined as  
   (B5) 
where  are the cumulative deviate data and  denotes the 
arithmetic mean of j data. The average of  over all the  subseries of length j 
increases with j at a rate which is parametrized by the so called Hurst exponent. It is a 
measure of the long term memory of the series and is directly related to the fractal 
dimension [366]. These concepts has been also applied to study and possibly predict the 
trend in the prices of financial instruments [367,368]. 
When applied to directional data, the definition of rescaled range needs to be modified, 
since the standard deviation S and the maximum and minimum operations lose their 
meaning. However they can be still used if each subseries of directional data is 
characterized by its CSω value. Moreover, we are not interested in the scaling properties 
of the range series as a function of the length of the subseries, which is useful to predict 
future trends in the series, rather to study the features of the time series throughout its 
length. Therefore, instead of calculating the range within each subseries of length j and 
averaging the resulting values over all the  subseries, we calculate the range by 
comparing the . subseries of the same length j. So we define the (scalar) range series 
        (B6) 
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where  is the  value for each of the  subseries of length j , and a new index, 
called Angular Transition Index: 
    (B7) 
where jmin is the minimum length of the subseries, chosen so that the corresponding 
 value keeps its statistical meaning. The algorithm used to implement this definition 
is the following:  
1) the angular time series is divided in  subseries of length j, starting from j= ; 
2) the  is calculated in each subseries: , l=1, ; 
3) the range  is calculated from the maximum and minimum values of , 
l=1, ; 
4) steps 1-3 are repeated by increasing the value of  of one unity, so decreasing 
the length j of the subseries; 
5)  is taken as the maximum value of the series , =2, . 
In practice, the computational time is greater reduced, while producing similar results, if 
step 5 is replaced by: 
5) the iterations of steps 1-3 are stopped when  and  is set to 
. 
The rationale of the procedure is the following: if the time series angles fluctuate around 
a given direction, the values of  will vary smoothly throughout the time series and 
the values of the range series will be small, almost independently of the amplitude of the 
fluctuations. In this case the value of  will be also small. If instead a transition is 
present in the time series, the range series values will show an abrupt increase at that j for 
which at least one subseries does not include a transition (the  value for this 
subseries will be much lower than those of the other subseries). After that, the range 
series will saturate by increasing j, so that the procedure can be stopped at the occurrence 
of the first maximum and  will take a large value. Therefore the algorithm is able to 
recognize the presence of transitions, distinguishing them from random, even large, 
fluctuations. 
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C MD SIMULATION-BASED INTERPRETATION OF 2D NMR 
	  
C1 Dopamine can Modulate a-Synuclein Aggregation  
Under physiological conditions, AS self-associates into small oligomers and protofibrils that 
elongate into mature amyloid fibril	  [369]. The addition of dopamine (DOP) to pre-formed fibrils 
can disaggregate fibrils into small non-fibrillar soluble oligomers	  [370] . DOP can promote AS to 
form soluble SDS-resistant and Thioflavin T negative oligomers	   [370], which are off pathway 
intermediates to amyloid fibril formation. DOP is a dominant modulator of AS oligomerization 
into non-amyloid species	  [322], can inhibits fibril formation by via non-covalent interaction	  [143]. 
A number of studies suggest that the interaction of AS with DOP leads to the formation of AS- 
DOP quinone adducts [204]. This indicates that reactive intermediates of DOP oxidation, and not 
DOP itself, are responsible for modulating the aggregation properties of AS	  [371].  A number of in 
vitro studies	   [372]	   [373] [374]	   [375]	   [299]	   [300] have shown that DOP can modulate the 
aggregation of AS along distinct pathways	  [371]	  [373] and the interaction between AS and DOP 
leads to the selective death of neuronal cells	  [376] and the accumulation of misfolded AS in Lewy 
bodies	  [377]. This occurs at a 1:1 (AS: DOP) stoichiometry, which is consistent with the relative 
physiological stoichiometries found in cells between AS and dopaminergic neurons	   [98]. 
Cytosolic DOP readily undergoes redox reactions	   [378], generating toxic DA reactive quinones 
along with superoxides and hydrogen peroxide	   [379]. The increase in reactive oxygen species 
promotes oxidative stress and mitochondria dysfunction lead to neuronal cell death. The oxidation 
of excess cytosolic DOP leads to the formation of neuromelanin within dopaminergic 
neurons[378]. In the oxidative pathway [290] DOP is initially oxidized to form dopamine-o-
quinone (DQ) which subsequently undergoes a cyclization step followed by another oxidation step 
to form dopaminochrome (DC). DC itself is an unstable molecule and can undergo rearrangement 
to form 5,6-dihydroxyindole (DHI) which can then polymerize into melanin. Alternatively, DHI 
can be further oxidized to form indole-5,6-quione (IQ) that will subsequently form melanin. 
Neuromelanin is present at high levels in the substantia nigra region of the human brain [380]and 
accounts for the darken appearance of these neurons (figura) [381]. In PD, it is the neuromelanin 
containing dopaminergic neurons that are selectivity lost[380,381]. This raises the question of 
whether DOP or its oxidative intermediates have the ability to induce the conversion of oligomers 
into fibrils or whether these AS: DOP oligomers have the ability to slowly form fibrils.  
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C2 AS•DOP interactions 
AS•DOP Contacts 
	  
Figure C1 Selected MD Snapshots of AS/dopamine derivatives adducts. MD Snapshots of dopamine 
derivatives non-covalently bound to AS. Both 3D representation and interactions scheme are shown.  In the 
3D structure representation, AS is shown as a combinations of “lines” and “cartoon” representation, while 
the molecule is shown in “licorice”. The details of interactions are represented by schemes obtained with 
Ligplot program [302]. The HBs are indicated by dashed lines between the atoms involved, while HCs are 
represented by an arc with spokes radiating towards the ligand atoms they contact. The contacted atoms are 
shown with spokes radiating back.  
Figure C2 Binding of dopamine derivatives to the NAC region. Selected MD snapshots of the adducts 
between the NAC region of AS and DOP derivatives. The figure shows the binding of the IQ, DHI and DQ 
derivatives in specific representative configurations of AS. Graphical representations as in Fig. C1. 	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C3 Boundary conditions and convergence of MD trajectories 
 
Boundary conditions  
Minimum 
distance 
(Å ) 
AS•DOPH AS•IQ AS•DCH AS•DOP AS• DHI AS• DQ 
Frame First  Last  First  Last  First  Last  First  Last  First  Last  First  Last  
1 18.53 42.53 19.81 31.90 19.05 40.13 19.05 35.44 19.45 31.06 18.83 49.64 
2 27.38 24.89 19.32 39.67 18.96 51.99 18.93 28.77 20.17 24.23 18.41 27.13 
3 18.51 27.37 19.29 41.88 19.59 41.56 18.57 47.24 19.11 35.42 19.86 36.86 
4 17.58 42.45 18.51 20.36 18.13 30.44 18.86 38.63 18.59 45.06 18.50 18.88 
5 17.84 40.34 19.81 40.10 18.47 42.98 18.12 37.32 18.93 44.71 44.80 50.29 
6 18.87 54.52 18.49 47.92 18.73 25.90 18.59 25.85 19.17 20.46 18.54 32.11 
Table C1 Boundary conditions. Distances (Å) between the edge of the box and the nearest atom in the first 
and last frame of MD simulations for the six configurations of each AS•DOP adduct. 
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Convergence analysis  
 
<TotEnergy> 
[kcal/mol] 
∆TotEnergy/ 
<TotEnergy> 
[kcal/mol] 
R 
∆KinEnergy/ 
∆TotEnergy 
 
AS•DOPH 
1 -2.3378 e+05 1.1817e+03 0.0051 1.4263 
2 -2.6416 e+05 1.7723e+03 0.0067 1.5427 
3 -2.2090 e+05 1.1039e+03 0.0050 1.4684 
4  -3.7969 e+05 1.9278e+03 0.0051 1.4231 
5 -1.9961 e+05 954.3391 0.0048 1.5920 
6 -4.7573 e+05 2.2106e+03 0.0046 1.6003 
AS•IQ 
1 -2.3383e+05 1.6543e+03 0.0071 1.3630 
2 -2.6436e+05 2.1922e+03 0.0083 1.3301 
3 -2.2093e+05 1.4289e+03 0.0065 1.3712 
4 -3.7973e+05 3.6457e+03 0.0096 1.4672 
5 -1.9981e+05 3.9084e+03 0.0196 1.5915 
6 -4.7589e+05 5.0281e+03 0.0106 1.3780 
AS•DCH 
1 -2.3384e+05 1.5375e+03 0.0066 1.3638 
2 -2.6433e+05 2.1831e+03 0.0083 1.3299 
3 -2.3024e+05 1.7901e+03 0.0078 1.2494 
4 -3.7976e+05 4.4020e+03 0.0116 1.4663 
5 -1.9966e+05 1.5969e+03 0.0080 1.4397 
6 -4.7597e+05 5.3808e+03 0.0113 1.3771 
AS•DOP 
1 -2.3389e+05 1.3983e+03 0.0060 1.3703 
2 -2.6460e+05 5.0970e+03 0.0193 1.3231 
3 -2.2100e+05 1.5299e+03 0.0069 1.3695 
4 -3.7979e+05 3.0811e+03 0.0081 1.4694 
5 -1.9992e+05 3.8090e+03 0.0196 1.3499 
6 -4.7592e+05 4.5653e+03 0.0096 1.3659 
AS•DHI 
1 -2.3388e+05 1.5340e+03 0.0066 1.3741 
2 -2.6439e+05 2.0094e+03 0.0076 1.3305 
3 -2.2100e+05 2.1843e+03 0.0099 1.3628 
4 -3.7980e+05 4.1910e+03 0.0110 1.4659 
5 -1.9973e+05 1.5877e+03 0.0079 1.4044 
6 -4.7604e+05 5.6052e+03 0.0118 1.3594 
AS•DQ 
1 -2.3385e+05 1.5205e+03 0.0065 1.3567 
2 -2.6429e+05 1.7278e+03 0.0065 1.3577 
3 -2.3021e+05 898.2169 0.0039 1.2826 
4 -3.7967e+05 1.9208e+03 0.0051 1.4827 
5 -1.9963e+05 874.7428 0.0044 1.4608 
6 -4.7576e+05 468.7561 0.0098 1.7885 
Table C2 Energies analysis. For each configuration of AS•DOP adducts the following quantities are 
reported: the average of the total energy over simulation time (<TotEnergy>), the fluctuations of the total 
energy with respect its average value (∆TotEnergy/ <TotEnergy>), the ratio (R) between the fluctuations of 
the total energy with respect the error on the mean of the total energy, the fluctuations of the kinetic energy 
with respect the fluctuations of the total energy (∆KinEnergy/∆TotEnergy).  
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C4 MD- derived quantities 
Salts-bridges 
 
Structure 
number 
1 2 3 4 5 6 
% SB 5% 1% 39% 14.7% 37.7% 2.3% 
Residues  K96, K97, 
D98, D121, 
E123, E131, 
D135, E137, 
E139 
 
E123, E130, 
E131, D135 
E137, E139  
E46, D98, 
K102, E104, 
E105, E110, 
E114, D115, 
D119, D121, 
E123, E126, 
E137, E139  
K96, K97, 
E104, E114, 
D115, D119, 
E126, E130, 
E131, D135, 
E137 
 
K97, K102, 
E104, E105, 
E110, E114, 
D119, D121, 
E123 , E126 
 
E57, E61, 
K96, K97, 
D98, E104, 
E114 
 
Table C3 Salts-bridges (SBs) population (percentage of salt-bridges over all the simulation time) for the six 
configurations of AS•DOPH adducts. The residues involved in the SBs are reported. The SBs are calculated 
using the VMD toolbox Salt bridges Plugin version 1.1. [313]  
End-to-end distance 
E-E(Å) AS•DOPH AS•IQ AS•DCH AS•DOP AS•DHI AS•DQ AS (no ligand) 
1 68.1±18.1 70.5±13.3 64.9±16.8 75.5±15.9 92.1±12.2 45.6±17.2 63.3±16.8 
2 84.3±21.5 67.6±8.4 37.3±14.7  79.6±12.4 85.4±13.9 61±16.3 72.7±8.0 
3 64.1±11.4 43.2±15.6 51.7±18.5 48.9±16.9 83.6±17.7 68.3±7.2 79.7±18.1 
4 91.4±13.6 100.2±13.2 87.2±10.6 46.6±24.2 86.3±21.2 88.7±13.0 106.4±12.1 
5 57.7±23.7 44.3±16.5 56.4±16.1 51.9±18.0 62.8±15.2 62.5±13.1 70.5±13.6 
6 126.8±12.9 112.9±17.1 111.2±21.6 130 ±13.5 130.2±10.4 148.5±13.1 129.2±19.2 
Table C4 Average values of the End-to-End (E-E) distance (Å) for the six configurations of free AS and of 
each AS•DOP adducts measured overall the MD trajectories.  
 
Gyration Radius 
Rg (Å) AS•DOPH AS•IQ AS•DCH AS•DOP AS•DHI AS•DQ AS (no ligand)  
1 30.3±3.6 35.0±1.5 29.4±2.6 31.2±3.8 34.2±1.7 26.6±4.8 24.8±7.4 
2 31.2±3.2 26.0±2.7 22.3±4..8 30.6±2.8 31.8±1.7 25.4±4.1 28.0±4.1 
3 27.0±2.6 29.0±3.4 24.6±4.8 25.1±4.2 33.2±1.2 26.8±3.8 27.5±3.9 
4 31.4±4.7 35.5±3.2 40.4±2.1 28.9±6.7 36.0±3.2 39.3±5.0 38.3±5.0 
5 22.1±2.8 20.0±2.4 21.7±2.3 20.1±3.1 20.5±2.3 20.6±3.1 21.2±2.4 
6 38.8±5.0 35.5±5.5 37.2±4.9 39.3±4.8 44.1±2.9 46.5±2.2 42.6±5.3 
Table C5 Average values of Rg (Å) for the six configurations of free AS and of each AS•DOP adducts 
measured overall the MD trajectories.  
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Figure C3 MD-averaged values of the Rg of the six configurations of AS calculated overall the trajectories. 
The cyan shaded region indicates Rg’s average values along with its standard deviation of AS (at neutral pH 
and room temperature) as inferred from SAXS, NMR and Single Molecules FRET experiments [8,30,322-
326,382]. 
 
Reference Radius of gyration (Å) Technique 
Dedmon et al 
[30] 
24.7  NMR 
Li et al [382] 40 ±1 SAXS 
Nath et al [326] 33 ±3 Single Molecule FRET 
Uversky et al 
[324] 
40 ±1 SAXS 
Tashiro et al 
[325] 
25.5 SAXS 
Rekas et al [322] 36 ±1  SAXS 
Salmon21 et al [8] 22.6 NMR+PRE 
Binolfi et al [323] 40±2 SAXS 
Table C6 Experimental values of the Rg of AS reported in the literature for AS at neutral pH and room 
temperature. The standard deviation is expressed when reported in the corresponding reference. The 
technique used to measure Rg quantity is reported. 
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21	  Details of experimental measurements of RDCs and PREs have been published elsewhere	  [383]	  
[384]	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Figure C4  [Degree] for residues experiencing Δcs in the 2D 1H-15N HMQC NMR 
experiments measured in this work. 
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D STRUCTURAL PROPERTIES OF ACETYLATED A-SYNUCLEIN 
	  
D1 Set up of the system 
 
SYSTEM AS  SYZE ( NUMEBER ATOMS) 
1 ca. 92,000 
2 ca. 100,000 
3 ca. 84,000 
5 ca. 145,000 
5 ca. 78,000 
6 ca. 174,000 
Table D1 System size for each AS conformer in water box . The numbers of atoms is reported. 
	  
Figure D1 Distribution of the potential energy for replicas respectively with 16 (left) and 32 (right) 
effective temperatures of the protein, each of one run for 400 ps for the first cluster. The potential energy is 
calculated as follow: Epp + (1/2)(Tm/T0)1/2Epw, where Epp and Epw are the protein intermolecular energy and 
the interaction energy between the protein and water, respectively; while T0 and Tm are the effective 
temperature of the lowest temperature replica and of the m-temperature replica, respectively.  
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D2 Comparison with experimental chemical shift 
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Figure D2 Comparison between calculated and experimental CSs of the Hα, HN, Cα Cβ and N atoms of 
Ac-AS cluster  2-6. The experimental data set considered is reported in the supporting information of ref 
[347]. The CSs calculated from the average trajectories are depicted with blue dots, the ones from the best 
frame trajectories with red dots.  
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D3 Secondary structures time-evolutions 
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Figure D3 Time evolution of secondary structures: α-helix, β-sheet, turn, and B-bridge for each of the six 
cluster 
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Last frame 
 
SS 
Cluster 
Average 
1 2 3 4 5 6 
AS α-H 6 2 2 1 2 1 2 
 β -s 1 10 9 1 3 1 4 
 T 17 12 15 11 14 11 13 
 BB 2 0 1 3 3 2 2 
Ac-AS α-H 0 4 0 0 0 0 0 
 Β-s 0 0 0 0 0 0 0 
 T 25 9 16 12 7 0 13 
 BB 0 2 0 2 2 0 0 
Variation α-H 26 2 -2 -1 -2 -1 -2 
 Β-s     3 -10 -9 -1 -3 -1 -4 
 T -8 -3 1 1 -7 -11 -2 
 BB -2 2 -1 -1 -1 -2 -1 
Table D2 The values refer to the last frame of simulations. The specific secondary structure (SS) content 
of AS and Ac-AS indicated as: α-H (α-helix), β-s (β-sheet), T (turn), and BB (B-bridge) are reported for each 
cluster (1-6). The average percentage is reported in the last column. The variation of the specific SS content 
between the two forms of protein is also reported. 
 
 
MD average 
 
SS 
Cluster 
Average 
1 2 3 4 5 6 
AS α-H 6 2 2 1 2 1 2 
 Β-s 1 10 9 1 3 1 4 
 T 17 12 15 11 14 11 13 
 BB 2 0 1 3 3 2 2 
Ac-AS α-H 2 3 0 3 1 2 2 
 Β-s 0 0 0 0 0 0 0 
 T 14 13 14 12 13 13 13 
 BB 1 2 0 0 2 0 1 
Variation α-H -4 1 -2 2 -1  1 -1 
 Β-s -1 -9 -9 -1 -3 -1 -4 
 T -3  1 -1 1 -1 2  0 
 BB -3 2 -1 -3 -1 -2 -1 
Table D3 The values refer to the averaged MD trajectory. The specific secondary structure (SS) content of 
AS and Ac-AS indicated as: α-H (α-helix), β-s (β-sheet), T (turn), and BB (B-bridge) are reported for each 
cluster (1-6). The average percentage is reported in the last column. The variation of the specific SS content 
between the two forms of protein is also reported.  
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D4 Boundary conditions and convergence of MD trajectories 
 
Minimum distance between periodic images  
 
 
Figure D4 Minimum distance between periodic images vs. time plots calculated for the lowest-effective 
temperature replicas (300 K) for all the AS systems. During the simulations, the distance between an atom 
and its images turned out to range from ~1  to ~5 nm.  
 
Structural fluctuations.  
The root-mean-square differences (RMSDs) obtained from our simulation on Ac-AS, reported for 
each cluster (Fig. D4) results considerably smaller than previously reported for AS [39]. The root-
mean-square fluctuations (RMSFs) (Fig. D5) reveled in average a higher mobility in 
correspondence of the C-terminal residues of the protein. 
Figure D5 RMSD vs. time plots calculated for the lowest-effective temperature replicas (300 K) for all the 
six Ac-AS systems.	  
	  	  
111	  
 
Figure D6 RMSF vs. residues number calculated for the lowest-effective temperature replicas (300 K) for all 
the sic Ac-AS systems. The average on the six trajectories is plotted in red. 
 
 
Convergence analysis after 1 ns of REST2 simulation 
 <TotEnergy> 
[kcal/mol] 
∆TotEnergy/ 
<TotEnergy> 
[kcal/mol] 
R ∆KinEnergy/ 
∆TotEnergy 
 
Cluster 
1 -988644 1322.50 0.0013
3 
0.5703 
2 -1075045 1381.92 0.0012
8 
0.5584 
3 -906829 1271.11 0.0014
0 
0.5597 
4 -1566171 1696.87 0.0010
8 
0.5620 
5 -841137 1216.74 0.0014
5 
0.5611 
6 -1880296 1858.12 0.0009
9 
0.5651 
Table D4 Energies. For each cluster the following quantities are reported: the average of the total energy 
over simulation time (<Total Energy>), the fluctuations of the total energy with respect its average value 
[Δ(Total Energy)], the ratio (R) between the fluctuations of the total energy with respect the error on the 
mean of the total energy, the fluctuations of the kinetic energy with respect the fluctuations of the total energy 
[Δ(Kinetic Energy)/Δ(Total Energy)]. 
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